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ABSTRACT
Type 1 diabetes (T1D) is a common, multifactorial disease with strong familial 
clustering. In Finland, the incidence of T1D among children aged 14 years or under 
is the highest in the world. The increase in incidence has been approximately 2.4% 
per year. Although most new T1D cases are sporadic the first-degree relatives are at 
an increased risk of developing the same disease. This study was designed to 
examine the familial aggregation of T1D and one of its serious complications, 
diabetic nephropathy (DN). More specifically the study aimed (1) to determine the 
concordance rates of T1D in monozygotic (MZ) and dizygotic (DZ) twins and to 
estimate the relative contributions of genetic and environmental factors to the 
variability in liability to T1D as well as to study the age at onset of diabetes in twins; 
(2) to obtain long-term empirical estimates of the risk of T1D among siblings of 
T1D patients and the factors related to this risk, especially the effect of age at onset 
of diabetes in the proband and the birth cohort effect; (3) to establish if DN is 
aggregating in a Finnish population-based cohort of families with multiple cases of 
T1D, and to assess its magnitude and particularly to find out whether the risk of DN 
in siblings is varying according to the severity of DN in the proband and/or the age 
at onset of T1D: (4) to assess the recurrence risk of T1D in the offspring of a Finnish 
population-based cohort of patients with childhood onset T1D, and to investigate 
potential sex-related effects in the transmission of T1D from the diabetic parents to 
their offspring as well as to study whether there is a temporal trend in the incidence. 
The study population comprised of the Finnish Young Twin Cohort (22,650 twin 
pairs), a population-based cohort of patients with T1D diagnosed at the age of 17 
years or earlier between 1965 and 1979 (n=5,144) and all their siblings (n=10,168) 
and offspring (n=5,291). A polygenic, multifactorial liability model was fitted to the 
twin data. Kaplan-Meier analyses were used to provide the cumulative incidence for 
the development of T1D and DN. Cox’s proportional hazards models were fitted to 
the data. Poisson regression analysis was used to evaluate temporal trends in 
incidence. Standardized incidence ratios (SIRs) between the first-degree relatives of 
T1D patients and background population were determined. 
The twin study showed that the vast majority of affected MZ twin pairs remained 
discordant. Pairwise concordance for T1D was 27.3% in MZ and 3.8% in DZ twins. 
The probandwise concordance estimates were 42.9% and 7.4%, respectively. The 
model with additive genetic and individual environmental effects was the best-fitting 
liability model to T1D, with 88% of the phenotypic variance due to genetic factors. 
The second paper showed that the 50-year cumulative incidence of T1D in the 
siblings of diabetic probands was 6.9%. A young age at diagnosis in the probands 
considerably increased the risk. If the proband was diagnosed at the age of 0-4, 5-9, 
10-14, 15 or more, the corresponding 40-year cumulative risks were 13.2%, 7.8%, 
4.7% and 3.4%. The cumulative incidence increased with increasing birth year. 
However, SIR among children aged 14 years or under was approximately 12 
throughout the follow-up. The third paper showed that diabetic siblings of the 
probands with nephropathy had a 2.3 times higher risk of DN compared with 
siblings of probands free of nephropathy. The presence of end stage renal disease 
(ESRD) in the proband increases the risk three-fold for diabetic siblings. Being 
diagnosed with diabetes during puberty (10-14) or a few years before (5-9) increased 
the susceptibility for DN in the siblings. The fourth paper revealed that of the offspring 
of male probands, 7.8% were affected by the age of 20 compared with 5.3% of the 
offspring of female probands. Offspring of fathers with T1D have 1.7 times greater 
risk to be affected with T1D than the offspring of mothers with T1D. The excess risk 
in the offspring of male fathers manifested itself through the higher risk the younger 
the father was when diagnosed with T1D. Young age at onset of diabetes in fathers 
increased the risk of T1D greatly in the offspring, but no such pattern was seen in the 
offspring of diabetic mothers. The SIR among offspring aged 14 years or under 
remained fairly constant throughout the follow-up, approximately 10. 
The present study has provided new knowledge on T1D recurrence risk in the first-
degree relatives and the risk factors modifying the risk. Twin data demonstrated 
high genetic liability for T1D and increased heritability. The vast majority of 
affected MZ twin pairs, however, remain discordant for T1D. This study confirmed 
the drastic impact of the young age at onset of diabetes in the probands on the 
increased risk of T1D in the first-degree relatives. The only exception was the 
absence of this pattern in the offspring of T1D mothers. Both the sibling and the 
offspring recurrence risk studies revealed dynamic changes in the cumulative 
incidence of T1D in the first-degree relatives. SIRs among the first-degree relatives 
of T1D patients seems to remain fairly constant. The study demonstrates that the 
penetrance of the susceptibility genes for T1D may be low, although strongly 
influenced by the environmental factors. Presence of familial aggregation of DN was 
confirmed for the first time in a population-based study. Although the majority of 
the sibling pairs with T1D were discordant for DN, its presence in one sibling 
doubles and presence of ESRD triples the risk of DN in the other diabetic sibling. 
An encouraging observation was that although the proportion of children to be 
diagnosed with T1D at the age of 4 or under is increasing, they seem to have a 
decreased risk of DN or at least delayed onset. 
Keywords: type 1 diabetes, twins, co-twin, concordance, heritability, familial 
aggregation, cumulative incidence, sibling, population-based, sibling recurrence 
risk, diabetic nephropathy, end stage renal disease, offspring, temporal trend, sex 
difference
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TIIVISTELMÄ 
Väitöstyön tarkoituksena oli tutkia tyypin 1 diabeteksen (T1D) sekä diabeettisen 
nefropatian (DN) kasautumista perheissä. Ensimmäisen osatyön tavoitteena oli 
tutkia monotsygoottisten että ditsygoottisten kaksosten konkordanssia T1D:n 
suhteen sekä määrittää geneettisten tekijöiden ja ympäristötekijöiden suhteellista 
osuutta T1D:n synnyssä. Toisen osatyön tarkoitus oli määrittää T1D:sta 
sairastavien sisarusten kumulatiivinen sairastumisriski T1D:een pitkän seuranta-
ajan kuluessa. Tavoitteena oli myös selvittää riskiin vaikuttavia tekijöitä, 
erityisesti indeksipotilaan (probandin) sairastumisiän vaikutusta sekä eri 
syntymäkohorttien välisiä eroja. Kolmannen osatyön päämääränä oli tutkia, 
onko perheen toisella diabeetikkosisaruksella kohonnut riski sairastua 
diabeettiseen nefropatiaan, jos aiemmin sairastuneella sisaruksella on jo todettu 
tämä tauti. Tarkoituksena oli myös selvittää, vaikuttaako diabeettisen 
nefropatian vaikeusaste (dialyysi ja munuaisensiirto) sisarusriskiin sekä sitä, 
onko diabetekseen sairastumisiällä vaikutusta nefropatiariskiin. Viimeisessä 
osatyön tarkoitus oli tutkia T1D:ta sairastavien henkilöiden lasten diabetesriskiä 
longitudinaalisesti ja sitä, eroaako diabeetikkomiesten ja -naisten lasten 
diabetesriski. Lisäksi tutkittiin, vaikuttaako diabeetikkovanhemman 
sairastumisikä lapsen riskiin ja erityisesti, onko sairastumisiän vaikutus 
samanlainen sekä diabeetikkomiesten että diabeetikkonaisten lapsilla. Myös 
lasten syntymäkohortin vaikutusta tutkittiin. 
Kolme laajaa, väestöpohjaista aineistoa oli käytössä. Ensimmäinen aineisto 
sisälsi kaikki Suomessa vuosina 1958–86 syntyneet kaksosparit (nuorten 
kaksosten kohortti, n=22,646 paria)). Toinen aineisto koostui vuosina 1965–79 
T1D:een alle 18-vuotiaina sairastuneista diabeetikoista (n=5,144) ja heidän 
sisaruksistaan (n=10,168) ja kolmas aineisto koostui em. diabeetikoista ja heidän 
lapsistaan (n=5,291).       
Tärkeimmät tilastolliset tutkimusmenetelmät olivat Kaplan-Meier-analyysi, 
Coxin regressioanalyysi, Poissonin regressioanalyysi ja rakenneyhtälömallitus. 
Monotsygoottisista kaksospareista 27.3 % oli konkordantteja T1D:n suhteen, 
kun taas ditsygoottisista kaksospareista vain 3.8 %. Rakenneyhtälömallituksessa 
parhaiten sopiva malli selitti sairastumiseen liittyvää vaihtelua sekä geneettisin 
että yksilöllisin ympäristötekijöin ja heritabiliteetin estimaatiksi saatiin 88 %. 
Identtiset kaksoset sairastuivat hyvin samanikäisinä. Suurin diskordanssiaika 
konkordanteilla pareilla oli 6.9 vuotta. Identtisten kaksosparien sairastumisiän 
korrelaatio oli 0.95, kun se epäidenttisillä kaksospareilla oli 0.43.  
Diabeetikkojen sisarusten pitkä seuranta osoitti, että T1D:n kumulatiivinen riski 
50 ikävuoteen mennessä oli 6.9 %. Riskiin vaikutti kuitenkin hyvin 
voimakkaasti probandin sairastumisikä. Jos probandi oli sairastunut 0-4, 5-9, 10-
14 tai yli 15-vuotiaana, 40 ikävuoden kumulatiivinen riski sisaruksilla oli 
vastaavasti 13.2, 7.8, 4.7 ja 3.4 %. Mitä myöhäisempään syntymäkohorttiin 
sisarus kuului, sitä suurempi oli kumulatiivinen riski. Kuitenkin, sisarusten ja 
taustaväestön ilmaantuvuuksien välinen standardisoitu ilmaantuvuussuhde (SIR) 
oli noin 12 koko seurantajakson ajan.  
Perheessä myöhemmin T1D:een sairastuneella sisaruksella oli 2.3-kertainen 
riski sairastua DN:aan, jos ensiksi T1D:een sairastuneella oli DN. Jos 
probandilla oli loppuvaiheen munuaistauti (dialyysi, munuaissiirre), riski kasvoi 
kolminkertaiseksi. Diabetekseen sairastumisikä vaikutti riskiin siten, että suurin 
riski oli henkilöillä, jotka olivat sairastuneet murrosiässä tai joitakin vuosia 
ennen murrosikää.  
T1D:ta sairastavien miesten lasten kumulatiivinen riski sairastua T1D:een oli 20 
ikävuoteen mennessä 7.8 %, kun taas diabeetikkonaisten lasten riski oli 5.3 %. 
Kaiken kaikkiaan diabeetikkomiesten lasten sairastumisriski oli 1.7-kertainen 
diabeetikkonaisten lasten riskiin verrattuna. Kun miesdiabeetikkojen lasten riski 
kasvoi sitä suuremmaksi, mitä nuorempana miesdiabeetikko oli diagnosoitu, 
naisdiabeetikkojen sairastumisiällä ei ollut vaikutusta lasten sairastumisriskiin. 
Lasten ja taustaväestön ilmaantuvuuksien välinen SIR oli noin 10 koko 
seurantajakson ajan, mutta kumulatiivinen riski oli sitä suurempi, mitä nuorempi 
syntymäkohortti oli kyseessä. 
Avainsanat: Tyypin 1 diabetes, kaksoset, kaksospari, konkordanssi, heritabiliteetti, 
perheaggregaatio, kumulatiivinen ilmaantuvuus, sisarus, väestöpohjainen, 
sisarusriski, diabeettinen nefropatia, loppuvaiheen munuaistauti, jälkeläinen, 
ajallinen trendi, sukupuoliero 
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ACE Angiotensin-converting enzyme                                                   
BCG Bacillus Calmette-Guérin –vaccine                                            
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CPR Central Population Register                                                                       
DERI  Diabetes Epidemiology Research International                                                
DN Diabetic nephropathy                                                                             
DN+ Diabetic nephropathy present                                                                 
DN- Diabetic nephropathy absent                                                                    
DZ  Dizygotic                                                                                               
ESRD End-stage renal disease                                                                          
HbA1c Glycosylated haemoglobin A1c                                                                    
HDR Hospital Discharge Register                                                                      
HLA  Human Leukocyte Antigen                                                                               
ID Personal identifier                                                                                   
ICA Islet cell antibody                                                                                             
λr Relative recurrence risk ratio                                                                        
λs Sibling recurrence risk ratio                                                                         
MHC  Major histocompatibility complex                                                        
MMR Measles, mumps, and rubella vaccine                                                       
MZ Monozygotic                                                                                            
RR Relative Risk                                                                                            
SIR Standardized incidence ratio                                                                          
T1D  Type 1 diabetes                                                                                       
T2D Type 2 diabetes                                                                                         
UAER Urinary albumin excretion rate 
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1  INTRODUCTION
Type 1 diabetes (T1D) is a disease primarily affecting young people although it can 
occur at any age. Most new T1D cases in any population are sporadic. Importantly, 
the first-degree relatives are at an increased risk of developing the same disease. 
Most studies on familial aggregation of T1D have been cross-sectional point-
estimations of the prevalence in the first-degree relatives at the time of diagnosis of 
the proband. The eventual phenotype of unaffected family members cannot be 
determined with certainty, however, without a long time of follow-up. Therefore, 
though rare, the natural way to study the topic is a longitudinal follow-up.
Finland is one of the few countries with nationwide and population-based twin 
registers that comprise the Old Twin Cohort and the Young Twin Cohort. In 
different populations the observed pairwise concordance for T1D is 13-52% in 
monozygotic twins but substantially less in dizygotic twins. Notably, the pairwise 
concordance was estimated to be 13% and probandwise concordance 23% in 
monozygotic twins in the Finnish Old Twin Cohort. Heritability was estimated to be 
74%. Methodological problems, however, may arise in twin studies and may also 
lead to false conclusions. In particular, in clinic-based opportunistic studies 
ascertainment biases tend to increase the number of concordant pairs. 
Finland has the world’s highest incidence of T1D in and it is increasing steadily. 
The lifetime cumulative risk is supposed to be less varying than the incidence 
between populations. The European ACE study hypothesizes that the T1D risk 
amongst first-degree relatives varies across populations in such a manner that it 
mirrors the pattern of disease incidence in the background population. Little 
information is, however, available on the birth cohort effects on the recurrence risk 
of T1D in the first-degree relatives in different populations.  
A number of studies has detected preferential sex-specific transmission of T1D. The 
offspring of fathers with T1D have an increased risk for T1D compared to the 
offspring of affected mothers. The nature of the factors responsible for this 
preferential transmission is unclear. One suggested explanation is that the observed 
preferential transmission might be due to fewer progeny to mothers than fathers with 
T1D. Few population-based studies with an optimal study design, in which the 
ascertainment of T1D of the offspring is confirmed through parents with T1D, 
however exist. 
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Increasing evidence shows that the age at onset of diabetes in the proband has an 
impact on the risk of diabetes in the first-degree relatives. Generally, the younger the 
proband when diagnosed the greater the risk in the close relatives. Only a few 
studies with rather inconclusive results, however, have assessed this risk of T1D in 
the offspring according to the age at onset of diabetes and according to the gender of 
the parent with T1D. 
Diabetic nephropathy (DN) with a multifactorial pathogenesis is one of the most 
severe late complications of diabetes affecting about one third of patients with T1D. 
Despite a large number of studies, the etiology of DN is still poorly understood. 
Although some studies have reported familial clustering of DN, these studies have 
mainly been clinic-based, cross-sectional, and with relatively small sample sizes. 
Studies providing truly population-based empirical estimates of the sibling 
recurrence risk of DN do not exist.  
In this thesis the first study evaluates the concordance rate of T1D in twins and 
further estimates the heritability for T1D in the Finnish Young Twin Cohort 
comprising 22,650 twin pairs. The second study provides empirical long-term 
estimates of the risk of T1D among 10,168 siblings of the Finnish population-based 
cohort of patients with T1D (probands) diagnosed at the age of 17 or under during 
the years 1965-79 (n=5,144). This study also investigated the cumulative risk for 
different birth cohorts, as well as a number of risk factors predicting the risk. The 
third study addressed the question of familial aggregation of DN and its magnitude 
in multiplex T1D families. Finally in the fourth study offspring recurrence risk for 
T1D was evaluated and the relation to gender and a number of other risk factors. 
The relation to the incidence in the background population was further explored. All 
studies investigate the effect of age at onset in the proband on the risk of T1D in co-
twins, siblings, and offspring as well as the risk of DN. A common feature of all 
these studies is that they utilize large, population-based cohorts of study subjects and 
follow the subjects longitudinally. 
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2  REVIEW OF THE LITERATURE 
2.1 Fundamentals of genetic epidemiology 
2.1.1 Genetic epidemiology and familial aggregation 
Genetic epidemiology is a comparatively new discipline combining aspects of 
statistics, genetics and classical epidemiology. The goal of genetic epidemiology is 
to elucidate the joint action of genetic and environmental factors in the distribution 
and determinants of diseases within human populations (1). Genetic epidemiology 
could be defined as a science, which deals with etiology, distribution, and control of 
disease in groups of relatives and with inherited causes of disease in population (2). 
The study of familial aggregation is a central theme in genetic epidemiology. 
Familial aggregation means the occurrence of a disorder at a higher frequency in the 
first-degree relatives of an affected person compared to the general population. 
Though, familial aggregation of disease is generally taken as evidence of a genetic 
etiological mechanism, environmental factors common to the family members 
cannot be excluded. Putative disease genes are not readily observed, but are 
hypothesized based on evidence from observed patterns of familial aggregation (3).  
The measure most commonly used to measure the degree of family aggregation in 
genetic epidemiology is called the relative recurrence risk ratio. The ratio between 
the recurrence risk of the disease in relatives divided by the population prevalence, 
usually denoted by λr (4). The λr parameter in itself does not directly express the 
genetic transmission, however, only the degree of family aggregation. One widely 
used measure of familial aggregation is the sibling recurrence risk ratio (λs), which 
is defined as the ratio of risk disease manifestation, given that one’s sibling is 
affected, as compared with the disease prevalence in the general population.  
2.1.2 Heritability 
Heritability (h2), answers the question of how much of the variation in the risk of 
disease can be attributed to genetic differences among individuals. Heritability is 
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defined as the ratio of genetic variance to the total phenotypic variance in the 
population (1). Heritability, and what it measures, is often misunderstood and 
misinterpreted as a measure of genetic control. Genetic control determines if the 
genes are biologically involved in a trait. Heritability does not indicate how 
important genes are in influencing a trait. Instead, it defines the extent to which 
genetic individual differences contribute to the observed phenotypic individual 
differences. It measures how the gentic control can vary. An extreme example of 
this is when a given phenotypic trait is under direct Mendelian control and all the 
individuals have the same genotype, no genetic variation and heritability could be 0 
(1). On the other hand in the Finnish Old Twin Cohort the heritability was estimated 
to be 74% and denotes considerable genetic variation. The heritability is strictly 
relative and a population specific measure (1). If the distribution of exposure to 
environmental factors changes, the heritability will change even within a population, 
even with the same set of genotypes.  
2.1.3. Mendelian patterns of inheritance 
Inheritance is the transmission of genetic information across generations. Mendelian 
type inheritance is the most common form of genetic inheritance. It is based on the 
transmission of a single gene in a dominant, recessive, or X-linked pattern. In 
autosomal dominant inheritance, only one copy of a gene causing a specific trait 
must be present in order for a person to display the trait. Homozygous and 
heterozygous individuals will be affected equally by the mutation and both will 
express identical forms of the trait. The second copy of a mutated gene in the 
homozygous individual does not cause a more severe disease. If a particular trait is 
autosomal recessive, two copies of the mutated gene causing this trait must be 
present in order for a person to possess the trait. Therefore, only homozygous 
individuals will be affected with the trait. Heterozygous individuals will not exhibit 
characteristics of the trait. These heterozygous individuals are called carriers, 
because they carry the trait and can pass it onto their children. Sex-linked traits are 
carried on the X and Y, or sex, chromosomes and may be either dominant or recessive. 
Most diseases have, however, a complex genetic and environmental basis (5). 
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2.1.4 Penetrance
The impact of a specific genetic factor on disease occurrence is usually measured in 
terms of penetrance. It is defined as the probability of the disease or phenotype of 
interest to develop among individuals who carry the specific genotype. It means that 
a given genotype does not always produce the same phenotype. A true dominant 
trait will have a penetrance of 100%. Many traits that are said to be dominant do not, 
however, have complete penetrance. For chronic diseases, the penetrance is 
equivalent to the lifetime risk of disease in carriers of the genotype (1). The 
expression of a given genotype may be modified by several factors, for example 
other genes or environmental factors (6). If the environmental exposure varies, the 
same genes at a given trait locus may have different effects on the phenotype, due to 
the genotype-environment interaction. If all individuals with a disease genotype 
show the disease phenotype, then the disease is said to be completely penetrant. 
Incomplete penetrance is a statistical concept to reflect that not everyone having the 
genotype of interest will manifest the phenotype of interest (1).  
2.1.5 Classical twin method 
The importance of twin studies has long been recognised in addressing the question 
of heritability, because twins provide a natural control for experiments that estimate 
the contribution of genetic factors to the phenotypic variability in human traits. The 
usefulness of twins in studying the genetic contribution to the trait was first 
suggested by Galton in 1875 (7). The systematic analyses of similarity between 
monozygotic twins (MZ) and dizygotic twins (DZ) was introduced by Siemens, who 
formulated the rule of pathology: any heritable disease will be more concordant in 
MZ twins than in DZ twins (8). The rationale is that genetic variance between MZs 
is zero, but DZs are genetically as variable as full siblings. MZ twin concordance 
rates of less than 100% emphasise the importance of environmental factors. The 
basic idea behind the classical twin study approach is to make a crucial assumption 
that both MZ and DZ twins share the intra-pair environment to the same degree 
(equal environment assumption). Therefore, the greater phenotypic similarity among 
MZ twins is consistent with a greater genetic similarity. MZ twins, however, are also 
often environmentally more similar than DZ twins and even in the complete absence 
of any genetic component a higher concordance can be detected in MZ twins than in 
DZ twins (9).   
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Resemblance between twins is measured as concordance if the trait is dichotomous 
and as correlation if the trait is continuous. There are two kinds of concordance; 
pairwise and probandwise concordance. The probandwise concordance is defined as 
the probability that one twin is affected with disease, given that the co-twin is 
affected (10). It is estimated by the ratio of the concordant to the sum of the 
concordant and discordant pairs (11). The pairwise concordance is defined as the 
probability that both twins are affected, given that at least one is affected, and is 
estimated by the ratio of the affected concordant individuals to the sum of the 
affected concordant and discordant individuals (11). Probandwise concordance can 
be interpreted as the recurrence risk in a co-twin of an affected twin and is more 
preferable of the two measures. 
Many diseases, like T1D, are familial but do not segregate in a mendelian way, but 
show multifactorial inheritance where both multiple genes and environmental 
factors play a role in the development of the disease. These can be modeled as 
threshold traits. According to the liability/threshold model proposed by Falconer 
(12), all of the factors, which influence the development of a multifactorial disorder, 
whether genetic or environmental, can be considered as a single entity known as 
liability. The liabilities of all individuals in a population form a continuous variable, 
which is assumed to have normal distribution and individuals whose liability 
exceeds a certain threshold develop the disease (Figure 1). Liability is presumed to 
be determined, in part, by numerous genes with low penetrance and environmental 
factors, each with small effects. The sharing of genes and environmental factors by 
relatives therefore results in a correlation of liability (12). 
Normally distributed curves are specified by only two parameters, the mean and the 
variance. Variances have the property of being additive when they are due to 
independent causes. Thus the overall variance of the phenotype (VP) is the sum of 
the variances due to the individual causes of variation, i.e. the environmental 
variance (VE) and the genetic variance (VG). VG can be further decomposed into 
additive (VA) and dominance genetic variation (VD), which is variation due to gene 
interactions like dominance (between alleles at the same locus) and epistasis 
(between alleles at different gene loci). Also?VE decomposes into common and unique 
environmental effects. Narrow sense heritability of the trait can be estimated as the 
fraction of the variance due to additive genetic factors VA/VP, whereas broad sense 
heritability is due to all additive and non-additive genetic factors (VA + VD)/VP (13). 
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Figure 1. Falconer's polygenic threshold model for dichotomous nonmendelian 
characters. Liability to the condition is assumed to be polygenic and normally 
distributed. People whose liability is above a certain threshold value are affected 
                 
2.2 Type 1 diabetes 
T1D is a common, multifactorial, and genetically heterogeneous autoimmune 
disease affecting about 0.3% of the world’s population and accounting for about 
10% of all diabetes (14). T1D was previously defined as insulin-dependent or 
juvenile diabetes. The new classification of diabetes, according to The American 
Diabetes Association and the World Health Organization, is now primarily based on 
the pathogenesis rather than on the requirement for insulin therapy (15; 16). T1D is 
now classified as type 1A (autoimmune) and type 1B (not immune-mediated). These 
phenotypes are differentiated by the presence or absence of autoreactive antibodies 
in the serum of affected individuals, stressing the involvement of immune-mediated 
mechanisms in type 1A diabetes. Type 1A is the most common form of diabetes 
among children and adolescents of European origin, and is usually characterized by 
an acute onset and dependence on exogenous insulin for survival. In adults, the 
disease is nearly as frequent as in children, but often with a less dramatic onset that 
may lead to misclassification as T2D and a delayed insulin treatment. About 60% of 
individuals with T1D are diagnosed in their adult life.  
In most cases, a preclinical period marked by the presence of autoantibodies to 
pancreatic β-cell antigens precedes the onset of overt T1D. At least one of these 
autoantibodies is present in 85–98% of newly diagnosed children (17). Everyone 
who develops T1D seems to be genetically predisposed to it. On the other hand, a 
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genetic predisposition does not guarantee that the disease will occur. T1D clusters in 
families, but does not segregate with a known mode of inheritance.  
2.2.1 Genetics of Type 1 diabetes 
The onset of T1D is attributed to both genetic risk factors and external triggers. The 
genetic component cannot be classified according to a classical model of inheritance 
but T1D is probably due to an interaction between different genes and 
environmental factors and thus a typical multifactorial, complex disease. The 
etiology of this disorder remains, however, unclear.  
The most studied and major genetic predisposition to T1D is conferred by genes in 
the HLA region on the short arm of chromosome 6 (6p21.3) (IDDM1). The association 
between HLA alleles and T1D was first documented in the 1970s (18-20). HLA 
genes encode molecules that are crucial to the immune system. The HLA region of 
chromosome 6 contains genes that encode class I (HLA-A, B, C), class II (HLA-DR, 
DQ, DP), and class III antigens, as well as numerous other genes that control 
immune response (Figure 2) (21; 22).  
The identification of the primary susceptibility determinants, within the MHC 
region, is confounded by strong linkage disequilibrium between the genes. Particular 
alleles of the HLA-DQA1, -DQB1 and -DRB1 loci all are primarily involved in the 
genetic predisposition to T1D, but due to strong linkage disequilibrium it is difficult 
to study the effect of individual HLA-DQ or –DR genes separately. 
Table 1 shows HLA Class II DR-DQ linkage patterns and T1D susceptibility in 
Caucasians (23; 24).  The highest susceptibility to T1D is associated with two 
combinations of DQA1 and DQB1 alleles: DQA1*0501.DQB1*0201 and 
DQA1*0301.DQB1*0302, which encode the HLA-DQ2 and HLA-DQ8 molecules. 
Two DRB1 alleles, DRB1*03 and DRB1*04 (which encode the DR3 and DR4 
molecules), are also associated with an increased risk of disease. About 90% of 
patients with T1D carry one or both of these haplotypes and the highest genetic risk 
of the disease is conferred by the DR3.DQ2/DR4.DQ8 heterozygous genotype.  
Although DQ8 is the principal disease determinant on this haplotype, its influence 
on disease risk may be modified by the DRB1 subtype. The DRB1*0401, 
DRB1*0402, and DRB1*0405 subtypes have been reported to increase the risk of 
diabetes independent of DQ8, whereas DRB1*0403 is neutral. “Protection” against 
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T1D is conferred by the DQA1*0102.DQB1*0602 haplotype, which encodes the 
HLA-DQ6.2 molecule. This molecule occurs in approximately 20% of the healthy 
caucasian population, but is rarely found among patients with diabetes (24).
The inheritance of particular HLA alleles account for over half of the genetic risk of 
T1D (24).  Comparison of disease concordance between HLA-identical siblings (15-
20%) and MZ-twins (35-45%) indicates that other loci have to be involved in the 
genetic transmission of T1D. Also, the fact that the risk of a sibling sharing none of 
the HLA-haplotypes with a proband is greater than the population prevalence 
suggests that additional factors are involved (25; 26).  
Table 1. HLA Class II DR-DQ linkage patterns and T1D susceptibility in 
Caucasians (23; 24) 
HLA-DR DQA1 DQB1 DRB1 SUSCEPTIBILITY 
DR2 0102 0602 1501 ”Protective” 
DR2 0102 0502 1601 Predisposing 
DR2 0103 0601 1502 Neutral 
DR3 0501 0201 0301 High Risk 
DR4 0301 0302 0401 High Risk 
DR4 0301 0302 0402 Predisposing 
DR4 0301 0302 0403 Neutral 
DR4 0301 0302 0404 Predisposing 
DR4 0301 0302 0405 High Risk 
DR4 0301 0301 0401 Neutral 
DR4 0301 0303 0401 Neutral 
DR6 0101 0503 1401 ”Protective” 
DR7 0201 0303 0701 ”Protective” 
Figure 2. Gene map of the human leukocyte antigen (HLA) region 
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Genome-wide linkage scans have enabled the identification of additional 
chromosomal regions that might contain susceptible genes for T1D (27-31). These 
scans have confirmed that the HLA gene region is the major genetic determinant of 
T1D risk, but they have further provided evidence that approximately twenty regions 
of the genome are also linked to susceptibility (Table 2) (23). The symbols of these 
loci are  labeled from IDDM1 to IDDM18 (www.gene.ucl.ac.uk/nomenclature).  
Polymorphisms in the regulatory region of the insulin gene INS (IDDM2) have been 
shown to be the second most important and plausible candidate of the T1D 
susceptibility and contributes to about 10% of the genetic susceptibility (31; 32). Also 
the gene CTLA4 (IDDM12) is a leading candidate gene outside the HLA region (24; 
33). The contribution of most of the candidate genes outside the HLA region to the 
T1D susceptibility, however, has turned out to be difficult to prove unequivocally.  
Table 2. Susceptibility loci for T1D, chromosome location as well as candidate 
genes or microsatellite markers (23) 
LOCUS CHROMOSOME CANDIDATE GENES OR MICROSATELLITES 
IDDM1 6p21 HLA-DR/ DQ 
IDDM2 11p15.5 INS-VNTR 
IDDM3 15q26 D15S107 
IDDM4 11q13 MDU1, ZFM1, RT6, FADD, LRP5 
IDDM5 6q25 ESR, MnSOD 
IDDM6 18q12-q21 D18S487, D18S64, JK (Kidd locus) 
IDDM7 2q31 D2S152, IL-1, NEUROD, GALNT3, HOXD8 
IDDM8 6q25-27 D6S264, D6S446, D6S281 
IDDM9 3q21-25         D3S1303, D3S1589, D3S3606 
IDDM10 10p11-q11        D10S193, D10S208, D10S588, D10S1426 
IDDM11 14q24.3-q31        D14S67 
IDDM12 2q33 CTLA-4, CD28 
IDDM13 2q34 D2S137, D2S164, IGFBP2, IGFBP5 
IDDM14 2q34-q35 NCBI # 3413 
IDDM15 6q21 D6S283, D6S434, D6S1580 
IDDM16 14q32 IGH 
IDDM17 10q25 D10S1750-D10S1773 
IDDM18 5q31.1-33.1 IL12B 
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2.2.2 Race and ethnicity 
One of the most striking characteristics of T1D is the marked geographic and ethnic 
variability in incidence (34-36). T1D predominantly affects europid populations in 
Europe and other continents but is less frequent in African, Asian, and Native North 
American populations. Notable differences, however, also exist within ethnic groups 
in neighboring countries like the Nordic countries and Estonia. Considerable 
differences exist in the annual T1D incidence in children, ranging from 0.1 per 
100,000 in China and Venezuela to over 50 per 100,000 in Finland in children ≤14
years of age (36). This represents hundreds-fold variation between different 
populations. Clear geographical patterns such as the polar-equatorial gradient, 
cannot be seen in the incidence rates (36). The distribution of diabetes-associated 
HLA-genotypes explains a part of the variation (37), but environmental and life-
style associated factors must contribute to the remarkable variation in incidence.  
Some examples exist of a large difference in incidence between populations with 
relatively similar ethnic and genetic constitution. The Scandinavian countries are 
characterized by a high disease incidence. In contrast, the neighboring Russian 
Karelia and the Baltic countries display a low incidence rate (38; 39). A six-fold 
gradient has been observed in the incidence of T1D between Finland and Russian 
Karelia, where one can also find one of the sharpest welfare gradients in the world 
(40). The population in Russian Karelia lives under entirely different socioeconomic 
circumstances than the Finnish population, although they partly share the same 
ancestry. This suggests that environmental triggers that vary among these countries 
contribute to the steep differences in the incidence rate.  
Noticeable within-country variations have also been observed. More than a six-fold 
variation in risk exists in Italy between the mainland and the island of Sardinia (41). 
Also in China a nearly 50-fold within-country variation has been observed (36).  
2.2.3 Gender and age
A sex bias is a characteristic of autoimmune diseases (42). In contrast to most 
autoimmune diseases, male predominance occurs in T1D. The overall sex ratio is 
roughly equal in T1D with only a minor male excess observed in children diagnosed 
under the age of 15. After puberty males seems to be more commonly affected than 
females (43-45). Several mechanisms for these differences have been explored, such 
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as the effects of sex hormones on the immune system, but the reasons are not yet 
known (42). The earlier observed association between a male excess and a high 
incidence of T1D, in contrast to a female excess in the low incidence countries was 
not confirmed in a relatively recent studies (36; 46).  
T1D like many other multifactorial diseases shows a variable age of onset. T1D can 
develop at any age, but predominantly occurs in children and young adults. The 
disease status of unaffected family members cannot be determined with certainty 
without a long follow-up time. The peak of T1D expression is seen between ages 
10-14, but several countries have reported that the age at onset has showed a trend 
towards an earlier onset (47-51). T1D may represent a heterogeneous disorder with a 
different pathogenesis in patients with earlier onset compared to later onset of the 
disease. A very young age at onset of T1D may be under a different genetic control 
than a later onset of T1D (52-54). A significantly higher percentage of non-DR3/non-
DR4 genotypes and a lower percentage of DR3/4 genotypes has been found in patients 
with later onset (55). Clinical subtypes of T1D can be divided into acute onset that 
mainly occurs in young patients or a slowly progressive form of β-cell destruction 
(56). A greater relative increase in incidence in individuals under five supports the 
importance of exposures operating early in life. 
2.2.4 Environmental risk factors 
During the recent years, the role of several environmental factors in the etiology of 
T1D has been extensively researched. Despite this no environmental agent 
responsible for triggering T1D has been conclusively identified. Table 3 summarizes 
the environmental factors that have been suggested to associate with T1D, either 
causative or protective. Seasonal variation in the onset of T1D has been observed 
worldwide with the largest proportion of cases diagnosed during fall and winter and 
the lowest during the summer, which has been interpreted as coincidence with the 
time of enterovirus infections (57-60). Many reports of epidemiological association 
between enterovirus infections and T1D have been brought out (61; 62). A new 
observation in the Finnish DIPP Project is a similar seasonality in the appearance of 
autoantibodies in non-diabetic, genetically susceptible children parallel the seasonal 
pattern of enterovirus infections (63). One hypothesis is that the increase in the 
incidence of T1D in Finland could be due to a parallel change in the epidemiology 
of enterovirus infections (64). The DIPP study further showed that the frequency of 
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enterovirus infections has rapidly decreased in the Finnish population as a 
consequence of modern life-style and increased hygiene.  
A number of other viruses have also been associated with T1D. These include 
rubella, mumps, cytomegalovirus, Epstein-Barr virus, retrovirus, and rotavirus (65-
67). Viruses are capable of causing a direct cytolytic effect or of triggering an 
autoimmune process that leads to the destruction of β-cells (68). The mumps virus 
was the first to be implicated in the development of human T1D. Several cases were 
reported in whic the mumps infection preceded the onset of T1D (67).  
Like the virus infections, vaccinations also affect the immune system early in life. A 
link between childhood vaccinations and the development of T1D has been 
investigated, but most studies have not been able to find an increased risk of T1D 
associated with vaccination (69-71). Vaccines may have a biological effect by 
themselves or an impact on the incidence of T1D due to the elimination of certain 
viral infections. A follow-up study in Finnish children did not find an increased risk 
of T1D associated with Haemophilus influenzae type b vaccination or with the 
number of vaccinations received (72). Neither did a large Danish study (70). 
A number of studies have investigated the relationship between dietary factors and the 
risk of T1D. Such factors include early introduction of cow’s milk supplement, 
duration of breast-feeding, vitamin D, vitamin E, zinc, nitrate, and nitrite compounds 
(73-75). The possible protective role of breast-feeding and harmful effect of early 
introduction of cow’s milk in the development of T1D have been proposed, but the 
results have remained controversial (75-78). Vitamin D supplement in the first year of 
life and already during prenatal life is associated with a decreased risk of T1D (79-82).  
Toxic substances in the environment, other than infectious agents or exposures that 
stimulate an immune response, are associated with the occurrence of T1D (83). 
Among toxins, the nitrates, nitrites and N-nitroso compounds are the main 
candidates playing an environmental role in the etiology of T1D (74; 84; 85). Nitrate 
can convert to nitrite and further into nitrosamines, which are known to be toxic 
substances capable of damaging the pancreatic ?-cells (85). Nitrates are found in 
vegetables, and nitrate and nitrite are used in meat products as food additives. In 
addition to food, nitrates are also found in drinking water due to natural occurrence 
and agricultural sources. Associations between regional water nitrate levels and the 
incidence of T1D have been reported in some ecologic studies (84; 86; 87). Finnish 
study, however, did not find such an association between the variation of T1D and 
the concentration of nitrates in the drinking water (85). 
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Novel potential environmental factors that may be associated with T1D are a 
bacterial toxin, the macrolide bafilomycin A1 produced by Streptomyces spp and 
antimicrobials (88; 89). An Australian study reported that the antibiotic bafilomycin 
A1 may induce changes in the pancreatic β-cells and a dysregulation of the insulin 
secretion in mice (88). Streptomyces species are found in the soil worldwide and 
they can produce many toxic compounds that infect vegetables and beets. Thereby 
humans could be exposed to high concentrations of bafilomycin A1. A recent 
Finnish study investigated the relationship between the use of antimicrobials before 
or during pregnancy or during childhood and the subsequent risk of T1D (89). 
Although no relationship between the use of antimicrobials in general and the risk of 
T1D was found, the maternal use of some specific antimicrobials, like the 
macrolides, before pregnancy was related to risk of T1D in the child. 
The relatively young age at onset and the long preclinical phase of T1D suggest that 
environmental risk factors may play a role in the fetal or perinatal period of life, 
when the immune system is maturing. The most commonly studied perinatal factors 
include birth weight, parental age at birth, birth order, pre-eclampsia, Caesarean 
section, and fetal-maternal blood group incompatibility (90-95). The most consistent 
finding is an association between an increased maternal age and an increased risk of 
T1D (90; 91; 94-97). A positive association between birth weight and T1D has also 
been found (92; 94; 98; 99). A study from Norway found an almost linear 
correlation between incidence rate and birth weight. The risk of T1D was more than 
two-fold higher in children with birth weights > 4500 g in comparison to newborns 
with the lowest birth weight (< 2000 g) (99). It is difficult to envisage whether the 
perinatal factors have a direct effect on the variation in risk of T1D or are they only 
potential markers of other unmeasured variables.
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Table 3. Environmental factors proposed to be involved in the pathogenesis of T1D 
VIRAL INFECTIONS 
(62; 67; 100)
CHILDHOOD
VACCINATIONS
(69-72)
DIETARY 
FACTORS (75)
TOXINS (83; 85; 
88; 89)
PERINATAL RISK 
FACTORS (90; 94; 
95; 99)
Mumps MMR Early 
introduction of 
cow’s milk 
N-nitroso 
compounds 
Maternal and 
paternal age at onset 
Enteroviruses BCG Breast feeding Bacterial toxin, 
bafilomycin A1 
Maternal weight 
gain during 
pregnancy 
Rubella Haemophilus 
influenzae type b 
Nitrate, nitrite, 
N-nitroso 
compounds 
Antimicrobials Intrauterine 
infections
Rotaviruses Polio  Fats Polychlorinated 
biphenyls (PCBs) 
Birth weight  
Retroviruses Tetanus Gluten  Birth order 
Cytomegaloviruses Diphtheria Vitamin D  pre- eclampsia 
Epstein-Barr viruses Pertussis Vitamin E  Caesarean section 
Zinc  Feto- maternal 
blood group 
incompatibility 
2.2.5 Type 1 diabetes in Finland 
Finland has the highest incidence of T1D in the world and the incidence rate has 
increased linearly since the 1950s (101), predominantly increasing in the younger 
age-groups (47). The incidence of T1D in children under 15 was predicted to reach 
50/100,000 cases per year around 2010, if the calendar-period effect would have 
been linear from the 1950s to 2010 (101).  The increase in the incidence, however, 
has in fact shown nonlinearity and already exceeded the milestone in the beginning 
of the millennium. The incidence increased linearly from 1965 to the beginning of the 
1990s approximately by 2.4% per year, but thereafter the increase has turned out to be 
even faster (Figure 3).  
A within-country variation has been observed in the risk of T1D in Finnish children. 
Notably, the incidence is higher in the rural heartland areas than in the urban areas 
suggesting that some geochemical, socio-economic, or behavioural factors may 
explain the geographic variation (102). Substantial regional variations in the HLA
genotypes and allele frequencies among different geographical regions of Finland 
also exist despite the highly homogenous population (103; 104).
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Figure 3. Incidence of type 1 diabetes in Finland during 1965-2005, 3-years moving 
averages, based on data from the Central Drug Register (CDR)
2.3 Risk of T1D in the first-degree relatives 
2.3.1 Historical review of family studies on diabetes  
More than 80% of T1D cases are sporadic and occur in an individual without a 
family history of diabetes at the time of diagnosis, but the remaining 20% clusters in 
families. As early as 1696, Richard Morton described a family of seven children, 
four of whom were diabetic (105).  
Repeated attempts, to characterize the occurrence risk of first-degree relatives of 
individuals with T1D have continued since the 1930s, have tried to determine the 
mode of inheritance from family studies. Pincus and White from the Joslin Diabetes 
Unit, first claimed in 1933 that diabetes mellitus is an inherited disease and showed 
that the disease was considerably more frequent among siblings and parents of a series 
of diabetic patients than among those of a series of non-diabetic subjects (106; 107).  
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The very wide range of variation both in respect to severity and age at onset made 
the genetics of diabetes particularly difficult to elucidate. Different hypotheses about 
the transmission of diabetes have been suggested, of which the first and most 
popular suggested that the disease is due to a single recessive gene (106-109). It was 
suggested that late-onset mild cases could be regarded as heterozygous for a gene 
which, in its homozygous form, gives rise to the early-onset severe type of diabetes 
(105). Smith et al. concluded that early-onset and late-onset diabetes represent 
different levels of liability to the same disease rather than being distinct diseases 
(110). Expected Mendelian ratios were, however, not found in family studies and a 
multifactorial inheritance of diabetes was finally concluded (111). One of the 
strongest arguments for the multifactorial hypothesis was the observation that when 
both parents were affected, the incidence of the disease among the siblings of the 
proband was greater than when one parent was affected (112).  
In the early family studies diabetic patients were not differentiated into type 1 
(insulin-dependent) and type 2 (non-insulin-dependent) diabetes. Harris (1950) was 
the first to show that early and late onset forms of diabetes do not have the same 
genetic background (105). In the 1960s several authors proposed that the genetic 
basis might be different for the early-onset type and the late-onset type of diabetes 
(109; 111; 113). The classification of the two common types of diabetes, as well as 
some additional forms of diabetes, was made at the end of the 1970s by two expert 
committees (114; 115).  
In the first reported family studies, early-onset and late-onset diabetes were kept 
together (108; 112), although in some studies the age at onset of diabetes in the 
probands was restricted to concern early-onset diabetes with subsequent insulin 
treatment. These criteria were, however, not required for the relatives. The original 
family studies were hospital-based and the family history material, of diabetes 
occurrence in relatives, was collected by questioning the patients treated at the 
diabetes clinics. Importantly, these investigations included only living probands and 
were thus prone to biases since deceased diabetics from the same cohort as the living 
ones could represent more serious cases of diabetes. Some studies combined all 
categories of first-degree relatives into one group with no possibility of 
differentiation between morbidity risk between parents, siblings, and children (116). 
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2.3.2 Type 1 diabetes in twins
The main interest of the first studies on diabetes in twins was focused on identical 
twins (117-121). Results that surprised the research community revealed that the early-
onset diabetes (< 40 years) might not be entirely genetic in origin. Tattersall and Pyke 
suggested that the concordance for juvenile onset diabetes in MZ twins may never 
reach 100% (120). In addition, they concluded that the risk of the unaffected twin 
becoming diabetic declines with increasing duration of discordance (120). 
Many studies have attempted to determine the concordance rate for T1D in MZ twins. 
The main weakness of these studies has been that most of them had ascertained 
diabetic twin pairs by advertising or sampling from diabetes clinics. This kind of 
ascertainment can easily lead to an excess of concordant pairs and thus biased 
estimates of the concordance rates. In addition, any comparison between MZ and DZ 
twins has not been possible by studying only MZ twins. Few of the studies were 
longitudinal, relying instead on cross-sectional analysis. The concordance rate in MZ 
twins in these studies (117; 118; 120; 122; 123) was estimated to be 25-50%. Later 
investigations on the topic used population based twin registries from Finland and 
Denmark, independently of the zygosity and diabetes status in the co-twin. In these 
studies the concordance rate was estimated to be between 13 and 38% (124; 125).  
Johnston et al. (126) provided the first demonstration of a genetic heterogeneity 
between concordant and discordant MZ twins. They showed that more of the 
concordant rather than the discordant MZ twin pairs were heterozygous for HLA-
DR3 and HLA-DR4. The increase in concordance was first seen in the younger (< 
20 years) compared with the older twin pairs (> 20). Such an increased risk in co-
twins of index twins diagnosed early in life was later confirmed (127-129). In the 
recently published study, Metcalfe et al. (130) found the disease associated high-risk 
INS genotype to increase the likelihood of MZ twins being concordant for T1D. For 
individual HLA-DQ antigens statistical differences also occurred between 
concordant and discordant twin pairs. An increased frequency of no high-risk HLA-
DQB1 alleles in discordant compared with concordant twins was seen. They 
therefore concluded that the load of both major histocompatibility complex (MHC) 
and non-MHC susceptibility genes have an impact on the disease penetrance. 
Importantly, besides these two studies (126; 130) very little information is available 
on differences in concordance to T1D caused by genetic heterogeneity.
To date, all studies have found that the concordance rate of MZ twins with T1D is 
much higher than that in DZ twins, indicating that genetic factors contribute to the 
disease. The vast majority of MZ twin pairs are, however, discordant for T1D 
providing the evidence that non-genetically determined factors also influence on 
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susceptibility to the disease. The investigation of the Finnish Old Twin Cohort 
showed the probandwise concordance to be 23% and the pairwise concordance to be 
13% in MZ twins and 4.8% and 2.5% in DZ twins. The heritability was estimated to 
be 74% in the Finnish Old Twin Cohort (124).  
The concordance rate for T1D in MZ twins may change over time. Finland is one of 
the few countries with a population-based twin registry that consists of two 
temporally consecutive cohorts of twins, the Old Twin Cohort (born 1940-1957) and 
the Young Twin Cohort (born 1958-1986). This offers a rare opportunity to provide 
unbiased data on T1D among twins as well as to compare the concordance rates for 
T1D in two successive cohorts of twins throughout the recent decades when the 
incidence of T1D has changed substantially. If the increase of T1D that has been 
observed in Finland during the past decades is due to increasing exposure to the 
environmental risk factors, the concordance rate for T1D among MZ twins must 
have become higher over time.  
The risk seems to be the highest in the two first years after a diagnosis of diabetes in 
the index twin, but declines sharply at least in young onset twins. The median 
discordance time among MZ twins is about four years. If a MZ twin pair remains 
discordant more than six years it is unlikely that the unaffected twin will ever 
develop diabetes (127), although a significant late progression to diabetes after six 
years of discordance has been detected. It is noteworthy that a discordance periods 
of even 36 and 39 years before the outbreak of diabetes in the co-twin have been 
reported (129; 131).  
2.3.3 Sibling recurrence risk 
Table 4 shows some of the central studies reporting sibling recurrence risk of T1D in 
different populations. These investigations are not entirely comparable due to 
methodological differences. The risk of T1D for siblings, however, does not vary to 
a great extent from study to study. The risk of T1D for siblings is found to be 
between 4% and 6.5% with a recurrence risk ratio of 10-26 (45; 53; 132-142). 
Degnbol et al. concluded that the risk in siblings of probands with diabetes 
diagnosed at 20 or under was about ten times that in the general population, whereas 
the risk of the sibling of probands developing diabetes later in life does not differ 
from the risk in the general population (132). Based on this, they concluded that the 
early-onset and late-onset diabetes cannot share the same genetic background. Chern  
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et al. divided siblings according to the age at onset of diabetes in the probands into 
two groups under and over ten years in order to test the degree of heterogeneity in 
each group and found that the different risk of diabetes in these two groups is a 
function of the age at diagnosis of the probands (136). Later in the 1990s, Allen et 
al. confirmed this connection between progressively increasing risk and the 
decreased age at onset of diabetes in the proband (140). The coexistence of a 
diabetic child and at least one diabetic parent in the family was found to increase the 
risk in the siblings up to 10.5% (137). Further evidence was provided by a German 
study in which the risk for siblings of the T1D proband was four times higher if a 
parent also had T1D (138).  
Familial aggregation of T1D has been studied using a cross-sectional study design at 
the time of diagnosis of the proband or if the follow-up time has been limited. A 
long follow-up time is needed to elicit the phenotype of unaffected family members, 
because a large part of individuals with T1D are affected by the disease after 15. 
Longitudinal follow-up studies on this topic are rare.  
Table 4. Studies investigating the sibling recurrence risk for T1D 
STUDY COUNTRY PROBANDS 
(n)
SIBLINGS AT 
RISK (n) 
T1D RISK 
IN
SIBLINGS
Degnbol et al., 1978 (132)    Denmark 185 391 6.2% 
West et al., 1979 (133) Canada 518 1,080 4.1%* 
Gottlieb et al., 1980 (134) Boston, US 259 614 4.5%* 
Gamble et al., 1980 (135) UK 4,868 - 5.6% 
Chern et al., 1982 (136)   US 493 1,433 5.5% 
Wagener et al., 1982 (137) Pittsburg, US 1,128 2,578 4.4% 
Tillil et al., 1987 (138)          Germany 554 982 6.6% 
Dahlquist et al., 1989 (139) Sweden 3,503 - 4.3%* 
Allen et al., 1991 (140) Wisconsin, US 194 300 12% 
Gavard et al., 1992 (45) Pittsburg, US 1,774 3,966 6.3% 
Pociot et al., 1993 (141) Denmark 1,419 - 5.0%* 
Lorenzen et al., 1994 (142) Denmark 291 533 6.4% 
Gillespie et al., 2002 (53) UK 1,299 1,430 4.3% 
Steck et al., 2005 (143) Colorado, US 1,586 2,081 4.4% 
* at the time of diagnosis of patients with newly diagnosed T1D, T1D=type 1 diabetes 
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2.3.4 Offspring recurrence risk 
It became possible to study the frequency of T1D in offspring after insulin therapy 
became available and enabled survival and reproduction in patients with diabetes. 
Several family studies concerning sibling risk and offspring risk have overlapped. 
Table 5 summarizes the studies from the literature during the last three decades 
where offspring risk of T1D parents has been evaluated. The risk ranges from 3-6% 
depending on the study design, follow-up time, and the population where the study 
has been conducted.  
Gender-related effects seem to be present in the transmission of T1D from one 
generation to the next. The first support of such a preferential transmission of T1D 
was provided by epidemiological studies that demonstrated that fathers of T1D 
children were more likely to be affected than mothers (132; 137; 141; 144-147). 
Subsequent studies on recurrence risk in offspring of parents with T1D also revealed 
preferential sex-specific transmission of T1D. The offspring of fathers with T1D 
have a 2-3 times increased risk of T1D compared to the offspring of affected 
mothers. Warram et al. first described the differences in the risk of offspring 
according to the sex of the affected parent. By 20, 6.1% of the offspring of diabetic 
men, while only 1.3% of the offspring of diabetic women, were affected (148). The 
tendency that children of male probands have a higher risk than children of female 
probands was also found in studies published later (138; 149; 150). A large Finnish 
population-based study, as well as study from Denmark, confirmed the rather large 
difference in the risk transmitted from the diabetic mother and father (151; 152). It 
has further been observed that T1D fathers are more likely to transmit diabetes to 
their daughters and mothers to their sons, a phenomenon called preferential cross-
sex transmission (151; 153). Conflicting results are, however, also reported 
concerning the preferential cross-sex transmission (148; 152).    
The nature of the factors responsible for the preferential transmission is unclear. 
Several theories to explain the observed preferential transmission have been 
proposed, but so far none of them are unequivocally proven. These include selective 
loss of fetuses that carry T1D susceptible genes in women with diabetes, leading to a 
lower prevalence of T1D in the offspring of affected women than men (148). The 
rate of miscarriage among diabetic women is higher than in the general population, 
reported to be 15-30% (154-157). The main reason for spontaneous abortions in 
patients with diabetes is considered to be hyperglycemia at conception and early 
pregnancy, but selective loss of fetuses bearing diabetogenic genes can not be 
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excluded (158; 159). Fetuses exposed to maternal diabetes could also be protected 
from being affected with T1D in some way (148). Fetal exposure to islet 
autoantibodies in children born to mothers with T1D may be protective against 
future islet autoimmunity and diabetes.  The large BABYDIAB studying the 
offspring of T1D mothers found that the offspring who were GAD or IA-2
autoantibody positive at birth had a significantly lower T1D risk than offspring 
who were autoantibody negative at birth (160).  
Another explanation suggests that fetal β-cell development is accelerated in the 
hyperglycemic environment of a diabetic pregnancy. This earlier maturation of beta 
cells during the diabetic pregnancy might protect against diabetes in later life (161). 
Support for this hypothesis comes from the observations that children born to 
mothers who develop T1D after pregnancy have a higher risk of T1D than those 
born to mothers who already have diabetes (152). The risk of T1D in offspring 
could, however, also be a consequence of heterogeneity of the genetic background in 
the early-onset and late-onset T1D.  
Transmission ratio distortion, mainly of HLA-DR4-linked diabetes susceptibility, 
has also been suggested (162). It has been claimed that the transmission of HLA-
encoded susceptibility is influenced by parental sex. Fathers are reported to transmit 
HLA-DR4-positive haplotypes more frequently to their diabetic offspring than 
mothers. Contradictory evidence regarding a possible transmission rate distortion 
has been described for HLA genes in Finnish T1D families (163). Finally, it has 
been postulated that phenomenon of genomic imprinting, i.e. differential behaviour 
of genes depending on their parental origin, might be responsible for the preferential 
transmission of T1D, but this has not yet been convincingly demonstrated in  
complex diseases (164).   
It is thus not fully clear, if the observed preferential transmission really exists or if it 
is only a consequence of faulty study design and ascertainment biases. Many bias-
causing factors have been described that can lead to an apparent preferential 
transmission, even though there is no preferential transmission at all (165). When 
the study population is ascertained through the affected offspring and then the 
affection status of their parent examined, the higher prevalence of T1D in males in 
the background population can lead to the observation of more affected fathers than 
mothers. When the study population is ascertained through the affected parents, 
there may be a misclassification of mothers with gestational diabetes as T1D, fewer 
offspring in T1D mothers than in their male counterparts and a possible birth order 
effect (165).  
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Confirmation or refutation of the preferential transmission of T1D would have 
important and practical implications for the understanding of the etiology of T1D 
and for the design of genetic studies. It is important to eliminate bias-causing factors 
in order to resolve the existence of preferential transmission of T1D. Population-
based studies with optimal study design, where the ascertainment of T1D in the 
offspring is complete and through the diabetic parents hardly exist.  
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2.3.5 Family studies and age-dependent variation in the risk of T1D
Genetic, immunological, and clinical studies have attempted to investigate, whether 
heterogeneity between familial and non-familial forms of T1D exist. It has been 
suggested that familial cases are more genetically susceptible than non-familial. One 
of the most important risk factors in siblings is the sharing of both HLA-haplotypes 
with the proband. The risk of T1D in HLA-identical sibling is 15-20%, when it is 2-
9% for HLA haploidentical and 0-2% for HLA nonidentical sibling (26; 167; 168). 
Age-related genetic factors seem to strongly influence the risk of T1D in first-degree 
relatives (169). Table 6 shows different kinds of family studies that report the effect 
of age at onset of diabetes in the proband on the risk of T1D in the first-degree 
relatives. The cut-off point of age at onset of T1D in the proband differs in these 
studies, but generally, the earlier the onset of diabetes the greater the risk in the first-
degree relatives. This may indicate varying liability to diabetes that corresponds to 
the varying age at onset and may be due to more penetrant alleles or more severe 
forms of T1D at an earlier age. Age dependent HLA heterogeneity has been 
observed in Caucasian T1D patients. T1D patients diagnosed in early childhood are 
more likely to have HLA genes associated with high disease susceptibility. It seems 
that the both the rate of T1D and age at onset are directly related to the HLA-
DR,DQ genotypes (53; 55; 170-174). In a large family study, Gillespie et al. 
detected that half of the children who were diagnosed before five were heterozygous 
for HLA DRB1*03-DQA1*0501-DQB1*02/DRB1*04-DQA1*0301-DQB1*0302, 
and the frequency of the genotype decreased with an increase in the age at onset 
(53). Similarly in the recent US study, nearly half of patients who had an age at 
onset before five possessed the high-risk genotype DR3/DR4,DQ*0302 (173).  
The effect of parental age at onset of T1D on the recurrence risk of T1D in their 
offspring has been reported (139; 150; 152), but only few studies have distinguished 
between maternal and paternal differences. Some studies have suggested that the 
maternal age at onset has only a minor impact compared with the paternal age (150; 
152).  
There is an increasing interest to find out whether age-at-onset itself also exhibits 
familial clustering. Tattersall and Pyke already concluded in their early study that 
the genetic factors determine both the presence of diabetes and the time of its 
appearance based on the results of their identical twin study (120). Identical twins 
37
tend to develop T1D at a similar age, age at onset seems to be highly correlated 
(r=0.95) (175). Heritability for age at diagnosis of T1D has been evaluated to be 
74% (175). In addition, some studies have reported significant correlation between 
the ages at onset in the first-degree relatives with diabetes (141; 175; 176), but some 
studies have detected only moderate or no correlation (135; 147; 172). Too short 
follow-up times, however, may cause an artificial correlation between the ages at 
onset of T1D. Fava et al. suggested that variation in the incubated period of T1D is 
strongly genetically influenced (175). A strong association in the ages at onset 
between affected sibling pairs was observed, if the sibling pair shared both DR-DQ 
haplotypes (172).  
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2.4 Diabetic nephropathy 
2.4.1 Natural history of DN 
Diabetic nephropathy (DN) with a multifactorial pathogenesis is the major life-
threatening late microvascular complication of T1D and it is a leading cause of end 
stage renal disease (ESRD) in the Western world (177). The progression of DN 
includes three stages. The earliest clinical evidence is the appearance of an increased 
amount of albumin in the urine (albumin excretion rate [AER] ≥30 mg/day or 20 
μg/min), referred to as microalbuminuria. The second stage is overt nephropathy, 
also called macroalbuminuria or proteinuria (AER ≥300 mg/day or 200 μg/min), 
culminating in renal failure with uremia (177). DN increases the risk of 
cardiovascular diseases such as coronary heart disease, acute myocardial infarction, 
and stroke (178; 179). The relative mortality is extremely high in individuals with 
T1D and DN compared to individuals with T1D and normoalbuminuria (180). Only 
a minority, approximately one third, of patients with T1D are expected to develop 
DN (181; 182). The incidence of DN first increases linearly with the duration of 
diabetes, but 20-25 years post diagnosis of diabetes it starts to decline (181; 182). 
This indicates that a subset of individuals with T1D is at an especially high risk to 
develop DN. The reasons why only some patients develop DN, even if they have a 
long duration of diabetes, have remained unclear. The observed incidence pattern 
suggests that genetic factors predisposing to DN may play a role in regulating the 
processes that lead to DN.
2.4.2 Risk factors related with DN 
The risk of microvascular complications is known to increase with the duration of 
diabetes (181; 182). Hyperglycaemia is the major risk factor for DN (183; 184). The 
Diabetes Control and Complications Trial (DCCT) has shown that an intensive 
therapy for diabetes can reduce the risk of DN (185). Glycemia cannot, however, 
explain all of the variability in the risk of DN (181; 182). Some patients with a poor 
long term glycemic control do not develop DN if they have not done so by 30 years 
after the onset of diabetes, and vice versa many patients with a relatively tight 
glycemic control develop DN within a relatively short time after diagnosis of diabetes 
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(186). Hypertension is also closely associated with nephropathy (181; 187; 188), but 
whether it is primary or secondary to DN is not clear. Lipid abnormalities play a 
remarkable role in the rapid deterioration of kidney function (189; 190). Parental 
history of hypertension, type 2 diabetes (T2D), and cardiovascular diseases appear to 
be the risk factors for DN (191-193). Men with DN outnumber women (181).  
The effect of age at onset of diabetes on the risk of DN is not studied much. Puberty 
has been used as a boundary, dividing the onset of diabetes before, during, or after 
puberty. It has been suggested that pubertal and postpubertal duration of diabetes 
contribute more to the risk of diabetic complications than do the years before 
puberty (194-197). Conflicting results have been reported. Some studies have argued 
that it is solely the total duration of diabetes that affects the risk of DN (196; 198). A 
possible reason for the inconsistent results might be that all the years before puberty 
have been supposed to have an equal impact on the development of complications. It 
has been noticed, in later studies, that subjects diagnosed before five have a delayed 
onset of early retinopathy and microalbuminuria compared to those diagnosed after 
five (195; 197). Two very recent studies reported a reduced risk of ESRD in the 
patients whose diagnosis occurred at four or under (199; 200).  
Since the incidence of T1D is increasing the proportion of patients with severe 
complications like DN is also likely to increase. Because the age at onset of diabetes 
has become younger than before, the patients might also develop complications at a 
younger age than before. The pattern of progression to DN according to different 
ages at onset of diabetes is very little studied. 
2.4.3 Familial clustering of diabetic nephropathy 
Familial clustering of DN has been observed earlier in some studies (201-204). Data 
from the DCCT have also confirmed a familial aggregation of DN (205). However, 
most studies have been cross-sectional and/or clinic- rather than population-based, 
and the sample sizes have been relatively small. Seaquist et al. (201) showed a 
strong concordance of DN among sibling pairs with T1D in their pioneer study. This 
study was, however, based on only 37 families and the 26 probands with DN were 
drawn from the kidney transplant clinic. Although they showed for the first time the 
presence of familial aggregation of DN, the estimate of its magnitude might be 
severely biased. A Danish study estimated a nearly five-fold increased risk of DN in  
diabetic siblings of patients with DN compared to diabetic siblings of 
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normoalbuminuric patients (203). The third study on this topic from the Joslin 
Diabetes Clinic confirmed that the risk in siblings varied according to the renal 
status of the probands. This study found an incidence rate ratio of 2.5 for the 
diabetic siblings of probands with and without DN. Truly population-based sibling 
DN recurrence risk studies do not exist and the risk differences according to the 
severity of  DN in the probands has not been studied. 
Familial aggregation of DN and its co-aggregation with other pathogenetically 
important factors, particularly hypertension and cardiovascular diseases, make a 
genetic component likely. Hypertension, T2D, and cardiovascular diseases have 
been observed to cluster in families (192). Despite the lack of concordance for 
glycemia, strong concordance in severity and patterns of glomerular lesions was 
seen in sibling pairs with T1D (204). Snieder et al. (206) showed that levels of 
HbA1c, a measure of blood glucose regulation, are largely  genetically determined. 
Although these observations highlight the important role of genetic factors in the 
development of DN, whether factors contributing to the familial clustering are due 
to the genetic effects, similarity of shared environment among the siblings, or both, 
have remained unclear.  
2.4.4 Candidate genes on diabetic nephropathy 
Several candidate genes have been proposed in relation to the development of DN. 
The two major approaches in the search for susceptibility genes have been linkage 
analyses and association studies. Genome-wide scan is also conducted (207). The 
results have, however, been incompatible and the association has been found to be 
weak. Most of the genes considered as candidate genes for DN are the same that 
have been studied in hypertension, T2D, cardiovascular diseases, glucose 
metabolism, and dyslipidaemia (208). The genes coding for components of the 
renin-angiotensin system have received special attention, due to the central role that 
this system plays in the regulation of blood pressure, sodium metabolism, and renal 
haemodynamics. The ACE insertion/deletion polymorphism is the most studied 
candidate gene (209; 210). Despite the intensive research, the role of most of these 
candidate genes has remained controversial and thus far not a single gene has been 
unequivocally shown to be causally related to DN. 
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2.4.5 Changing incidence of DN
Diabetes management has improved greatly in the recent decades. Self-monitoring 
of the blood glucose, measurement of HbA1c, development of diabetes care 
equipments, and the frequent use of antihypertensive medications have emerged. 
These developments are presumed to manifest in improved prognosis of diabetic 
patients, reduced incidence of diabetic complications, and lowered mortality. 
Randomised clinical trials demonstrate that the risk of developing microvascular 
complications has fallen in recent years (183; 185). Bojestig et al. (211) were the 
first to report a dramatic decline in the incidence of DN in Sweden as a consequence 
of improved glycemic control. A remarkable decrease was actually observed 
between the cohort with diabetes onset from 1961 to 1965 and the subsequent 
cohorts. The following two groups, patients with onset of diabetes from 1966 to 
1970 and from 1971 to 1975, seemed to have an equal risk. Little can be said about 
the last diagnosis group, onset of diabetes between 1976 and 1980, because of 
insufficient follow-up time. The authors noticed that in their follow-up study of the 
same cohorts a significant decrease in the incidence of DN from that in the oldest 
cohort to that in all the other cohorts, but no significant difference appeared between 
the latter cohorts (212).   
Many other studies have also noticed a decrease in the incidence of DN (213; 214), 
but after the first observations many have also reported contradictory results. A 
nation-wide study from Iceland did not show any decline in the cumulative 
incidence of DN over time, when patients were compared according to the year of 
onset of T1D (215). A Danish study also did not reveal any decline with an 
increasing calendar year of onset of diabetes (216). A Finnish study did not either 
show any changes in the hospitalization rate due to DN (217). 
Temporal trends of ESRD have also been investigated recently (199; 214). A 
significant decline was observed in the 20-year cumulative incidence rates of ESRD 
for patients diagnosed from 1965 to 1969, 1970 to 1974, and 1975 to 1979 in the 
Pittsburgh cohort of patients with diabetes (214). A large Finnish population-based 
study reported a decreased incidence of ESRD (199). Only a sufficient follow-up 
time regarding the latest diagnosis group will reveal, if the decline in the incidence 
rate is a reality or if the onset of ESRD just shows a small time-shift. 
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3  AIMS OF THE STUDY 
The main aims were:    
1. To determine the concordance rates of T1D in MZ and DZ twins and estimate 
heritability for T1D in the Finnish Young Twin Cohort and evaluate the possible 
changes in the concordance for T1D in the MZ twins. The objective was also to 
study the length of discordance time of twin pairs and how does it depend on the 
zygosity and the age at onset of diabetes in the index twin. 
2. To obtain long-term empirical estimates of the risk of T1D among the siblings of 
T1D patients and to find out the factors influencing the risk including birth cohort 
effect, the age at onset of diabetes in the proband, sex, parental history of young-
onset diabetes, and maternal and paternal age at delivery.   
3. To establish if DN is aggregated in the Finnish cohort of families with multiple 
cases of T1D and assess the magnitude of aggregation first time in the population-
based cohort. This study was also going to define whether the risk of DN in the T1D 
siblings is varying according to the severity of DN in the proband and according to 
the age at onset of diabetes. The aim was also to study the sex differences and 
effects of calender year at onset of diabetes on the risk of DN in the T1D siblings. 
Also the effect of parental history of T1D, T2D, and hypertension were studied as 
risk factors for DN.
4. To assess the cumulative incidence of T1D in the offspring of T1D parent and 
find out the extent to which the sex of the T1D parent influence on the risk of T1D 
in the offspring and to identify the possible modifying factors, especially the effect 
of parental age at diagnosis of diabetes. The aim was also to find out whether the 
parent-offspring transmission of T1D has changed over time and compare the 
incidence of T1D in the offspring to that of T1D incidence in the background 
population. 
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4  MATERIALS AND METHODS 
4.1 Study Population 
4.1.1 Finnish Young Twin Cohort
The Finnish Twin Cohort was established in 1974, which in its first phase comprised 
of over 17,000 like-sex twin pairs born before 1958, with both members alive in 
1967 (The Old Twin Cohort) (218). In 1987, the twin study was expanded to all like-
sex and opposite-sex twin births from 1958 to 1986 comprising 22,650 twin pairs 
(The Young Twin Cohort) (219). The cohorts were compiled from the Central 
Population Registry (CPR) of all Finnish residents. The Young Twin Cohort formed 
the study population in the study I (Table 7).  
Table 7. Finnish Young Twin Cohort: estimated zygosity distribution   
TYPE OF TWIN PAIRS NUMBER OF TWIN PAIRS 
OPPOSITE-SEX PAIRS 8,133 
LIKE-SEX PAIRS 14,517 
LIKE-SEX DIZYGOTIC PAIRS 8,133 
MONOZYGOTIC PAIRS 6,384 
ALL PAIRS 22,650 
4.1.2 Sibling and offspring recurrence risk of T1D and familial DN 
The studies II, III, and IV included family data from the nationwide Finnish 
population-based cohort of patients that had been diagnosed with T1D before 18 
between 1965 and 1979 (n=5,144 T1D cases, designated original DERI probands). 
This cohort was initially employed in the Diabetes Epidemiology Research 
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International (DERI) Mortality Study (220; 221). The case ascertainment in this 
cohort was virtually complete (222; 223).  
Figure 4 illustrates a three-generation pedigree of a DERI family. In studies II and 
III the proband (index case) within the sibship was defined as the sibling that was 
diagnosed first with T1D chronologically. Thus, if there were two original DERI 
cases (with onset of T1D during 1965-1979) in the family the first affected was the 
proband and the other was considered as the affected sibling. Descriptive statistics 
of the siblings in the DERI families are described in Table 8. All siblings (n=10,168) 
of DERI families were born in 1990 or before.
The study population in study III was composed of the families with at least two 
children with T1D (multiplex families) that were identified in study II.  
The study population in study IV consisted of the offspring of the original DERI 
probands. By the end of 2001 there were 5,291 offspring. Of these 2,297 (43.4%) 
were born to female probands and 2,981 (56.4%) to male probands. Offspring were 
mainly born between 1970 and 2001. Descriptive statistics of the offspring are 
described in Table 9.
Offspring (n=5,291)
Siblings (n=10,168)
Families (n=4,968)
Original probands (n=5,144)
Figure 4. Pedigree of a DERI family with three generations 
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Table 8. Subject characteristics of study population (II, III) 
CHARACTERISTICS NUMBER OF SIBLINGS 
Sex of  the sibling 
Male  
Female 
5,202
4,966
Family size                             Families (n) 
1 child                                                 682    
2 children                                         1,606    
3 children                                         1,230  
4 children                                            678    
≥5 children                                         772   
-
1,606
2,460
2,034
4,068
Total                                                4,968     10,168 
Birth year of the sibling 
<1960
1960-69
1970-79
≥1980
5,151
3,838
971
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Age at onset of T1D in the proband 
0-4 years 
5-9 years 
10-14 years 
≥15 years 
1,306
2,811
4,156
1,895
Table 9. Descriptive data of the study population (IV) 
CHARACTERISTICS FEMALE PROBAND MALE PROBAND ALL 
Number of probands 2,313 2,831 5,144
Number of probands with 
offspring
      
1,335 (57.7%) 1,440 (50.9%) 2,775 (53.9%) 
Number of offspring 
              Girls  
              Boys 
2,310
1,157
1,153
2,994
1,444
1,550
5,291 (13)* 
2,595 (6)* 
2,696 (7)* 
Year of birth of offspring 
            <1970 
            1970-79 
            1980-89 
            1990-99 
            2000-01 
3
253
906
1,032
116
1
269
1,124
1,416
184
4
522
2,028(2)*
2,438(10)*
299(1)*
* Both parents with T1D 
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4.2 Identification of family members and diabetes status -record 
linkages
Family members were identified from the Central Population Registry (CPR), in 
siblings and parents of the probands (studies II and III) and offspring and the other 
parent of the offspring (study IV). In the cases in Study II that one or both parents 
could not be found from the CPR, the family trees were traced from the church 
parishes by genealogical study. The vital status of the probands and their first-degree 
relatives were obtained by linkage of the records with the National Death Registry. 
The diabetes status of the twins, the first-degree relatives of the DERI-cases, and the 
other parent of the offspring of the DERI-cases were ascertained through several 
sources. The data were linked to the National Hospital Discharge Register (HDR), 
the Social Insurance Institution Central Drug Register (CDR), and the nationwide 
Finnish Diabetes Register for Children and Young Adults. Since 1970 (nationwide 
since 1972) the HDR lists discharges of all hospital patients and includes each 
patient’s ID code, dates of hospitalization admission and discharges, and up to four 
International Classification of Diseases (ICD) codes. Medication for diabetes is free 
of charge for diabetic patients in Finland. All patients receiving free medication for 
chronic diseases including diabetes are entered into the CDR.  
It is not always possible to unambiguously distinguish between the different types of 
diabetes based on the CDR or HDR. In addition, the date of diagnosis is not always 
reliable based on these registers. Therefore, the primary use of the HDR and CDR in 
Studies I-III was to trace the cases with diabetes as well as the places of their health 
care. Copies of the original medical records for all diabetic twins, DERI probands 
and their siblings with diabetes, and for the other diabetic parent of the offspring 
were obtained and reviewed in order to verify the type of diabetes and to define the 
date of manifestation of diabetes. Nonetheless, in study IV, where the first case of 
T1D occurred in 1983 and over 90% of cases with diabetes were diagnosed at 14 or 
before the data from the CDR and HDR were considered reliable. Practically all 
children with newly-diagnosed diabetes are hospitalized in Finland (146) and the 
date of onset of diabetes could be defined in Study IV as the date of the first hospital 
admission because of diabetes or the approval date for the free-of-charge medication 
for diabetes.
In order to find diabetic parents in DERI families, the data on the parents were also 
linked to the HDR and CDR. The onset of diabetes in parents was defined as the 
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date of the first hospital admission due to diabetes or the approval date for free-of-
charge medication for diabetes, whichever was earlier. Parents with early-onset 
diabetes were defined as those whose attained age at diagnosis of diabetes was 40 
years or under. 
4.3 Zygosity determination 
Questionnaires were mailed to all twins with diabetes and their co-twins with 
questions on zygosity, diabetes type, date of onset, start of insulin therapy, and 
history of diabetes among family members and they were also invited to give blood 
samples for confirmation of zygosity and ongoing genetic studies. Twin zygosity 
was determined by examining the responses of the twins to questions on the 
similarity of appearance and confusion between twins at school by using a set of 
decision rules (224). The same questions were earlier used in the Finnish Twin 
Cohort Study and this method has been validated in a subsample by the use of 11 
genetic markers (224). In addition, zygosity was confirmed by DNA analysis of 10 
highly informative polymorphic microsatellite loci (D3S1358, vWA, FGA, AMEL, 
THO1, TPOX, CSF1PO, D5S818, D13S317, D7S820) in 14 of 15 same-sex 
concordant pairs for T1D and when there was any doubt about zygosity as used 
routinely in paternity testing procedures at the National Public Health Institute. Only 
one diabetic pair with both members having moved abroad and both parents being 
deceased remained unclassified. 
4.4 Classification of diabetic nephropathy 
A potential diagnosis of DN was followed among sibling pairs with T1D until the 
end of 2001. In order to identify patients with DN, copies of original medical 
records, death certificates, and autopsy data for the probands and their T1D siblings 
were systematically reviewed. Overt nephropathy was defined as a urinary albumin 
excretion rate (AER) repeatedly exceeding 200 μg/min or 300 mg/24 h, or as a 24-
hour urinary protein excretion rate >0.5 g, or as a positive urinanalysis for protein 
using a reagent strip. Microalbuminuria was defined as an AER of 20-200 μg/min or 
30-300 mg/24 h. Normal AER was defined as an AER <20 μg/min or <30 mg/24 h. 
If AER was elevated due to pregnancy, urinary tract infections or other renal 
diseases the result was not considered diagnostic for DN. If the patient used any 
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antihypertensive medication, the classification of DN was based on the findings 
prior to the initiation of drug treatment. End-stage renal disease (ESRD) was present 
if the patient was undergoing dialysis or had received a kidney transplant. 
4.5 Ethical aspects of the study
This study was approved by The National Advisory Board on Health Care Ethics.
All subjects in the twin study who were asked to give blood samples received 
written information about the study prior to their participation and gave their verbal 
consents. Medical records were reviewed with the permission of the Ministry of 
Social Affairs and Health. 
4.6 Statistical methods 
4.6.1 Study I 
Concordance was estimated using both crude pairwise and probandwise 
concordance rates, each calculated separately for MZ and DZ twin pairs. (10). 
Because probandwise concordance can be interpreted as the recurrence risk in a co-
twin of an affected twin and thus comparable with the cumulative incidence of T1D 
in the co-twins Kaplan-Meier survival analysis was also used to estimate the 
probandwise concordance. Furthermore, in the survival analyses the co-twins were 
divided into two groups: those in which the index twin was diagnosed at 10 or 
younger and those in which the index twin was older than 10. The log-rank test 
served to test risk difference between groups. Intra-class correlations (tetrachoric) 
were calculated to estimate the degree of similarity within a twin pair.  
A polygenic, multifactorial liability model was fitted to the twin data to estimate the 
contribution of environmental and genetic factors to the susceptibility to T1D. It 
assumes that there is a normally distributed liability to the disease (12). When a 
certain level of threshold of liability is reached, the disease manifests. Analysis 
based on structural equation models permit formulation of models with components 
of variance; additive genetic variance (A), genetic variance due to dominance (D), 
environmental effects common to the twins (C) or unique environmental (E) sources 
of variation in the underlying liability to disease. Different combinations of models, 
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i.e. AE, ACE, ADE, and CE were fitted to the 2x2 contingency tables (disease 
present/absent in twin 1 versus disease present /absent in twin 2).  
The superiority of alternative hierarchically nested models was assessed by using the 
–2 log-likelihood statistic: the likelihood-ratio of alternative hierarchically nested 
models was calculated by the difference in their χ2-values which itself is χ2-
distributed with degrees of freedom equal to the of models compared (13). In 
addition, parsimony (as few parameters as possible) of the models was examined 
using AIC-value (Akaike's information criteria). The model with the lowest AIC-
value indicates the best goodness-of-fit and the parsimony. Analyses were carried 
out with the Mx-software package (225), which has been developed especially for 
twin analyses. 
4.6.2 Study II 
Kaplan-Meier analyses were used to provide the long-term cumulative risk for the 
development of T1D in siblings. Person-years were calculated from birth to the date 
of diagnosis of T1D, until death, or until the end of follow-up at the end of 2001. 
Analyses were also performed stratifying by sex, age of diabetes onset in the 
proband, year of birth (cohort effect), and parental age at delivery. The effect of 
several independent risk factors on the risk of T1D for the siblings was evaluated by 
a Cox regression analysis using a forward selection procedure. The predictors 
studied were sex of the sibling, sex of the proband, diagnosis age in the proband (0-
4, 5-9, 10-14, ≥15), parental history of young-onset diabetes (≤40 years), birth year 
(≤1970, 1970-1979, ≥1980), number of offspring in the family as continuous 
variable, and parental age at delivery (≤24, 25-29, 30-34, 35-39, ≥40). Model 
selection was based on likelihood ratio tests. Relative risks were calculated with a 
univariate analysis and with the best fitting multivariate model. 
4.6.3 Study III
For each sibling, the person-years at risk was calculated from the onset of diabetes 
to the date of DN diagnosis, death, or until the last urine screening test found in the 
medical records before the end of the year 2001. The cumulative incidence of DN, 
according to the duration of diabetes, was estimated by using the Kaplan-Meier 
survival analysis method. This was also conducted according to the presence and 
severity of DN in the proband and according to age at onset of diabetes. To identify 
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prognostic factors for the development of DN in diabetic siblings, the Cox’s 
proportional hazards model was fitted to the data. Sex, the age at the onset of 
diabetes (0-4, 5-9, 10-14, ≥15), the calendar year at the onset of diabetes (≤1970, 
1971-79, ≥1980), the DN status of the proband, the parental history of T2D and 
hypertension, and maternal age at delivery were entered into the model. Age-specific 
incidence rates of DN were calculated per 1,000 person years for the diabetic 
siblings of the probands with and without DN separately and according to sex. 
Incidence rates were also calculated by duration of diabetes, separately for men and 
women. 
4.6.4 Study IV
Follow-up started at birth and ended at the diagnosis of T1D, death, or the end of the 
year 2003. The data were grouped by age and calendar time (period) in 1-year 
classes. Poisson regression analysis was used to evaluate temporal trends in 
incidence. Standardized Incidence Ratios (SIRs) of T1D were calculated to 
determine the increase in the risk of T1D in the offspring of the parents with T1D 
compared with that in the background population for the period 1985-2003 for each 
of 5-year periods. The expected numbers of cases were derived by applying the age-
specific incidence rates of T1D observed at the same time in the background 
population, i.e. in Finland nationwide. The data on the newly diagnosed T1D cases 
nationwide were derived from the CDR. 
Kaplan-Meier analysis was used to estimate the cumulative incidence of T1D.  The 
analyses were also carried out stratifying the data by the age at diagnosis of T1D in 
the parent and the birth year of the offspring, separately in the offspring of fathers 
with T1D and mothers with T1D. To assess the effect of several independent risk 
factors on the risk of T1D among the offspring, univariate and multivariate 
regression analyses of the data were performed using the Cox proportional hazards 
modelling. In addition to the sex of the T1D parent, the predictors studied were sex 
of the offspring, year of birth of the offspring (< 1985, 1985-89, 1990-1994, ≥1995), 
age at diagnosis of the parent (0-4, 5-9,10-14,15-17), the parental age at delivery and 
the birth order effect. Interaction between variables was also tested. 
52
5  RESULTS 
5.1 Genetic liability of T1D (Study I) 
The record-linkages yielded a total of 303 cases with any type of diabetes by the end 
of the follow-up in 1998.  A total of 247 twins (in 228 twin pairs) with T1D, 28 with 
T2D, 15 with secondary diabetes, and 13 with gestational diabetes were identified. In 
the last group three patients with gestational diabetes were co-twins of T1D twins and 
were classified as discordant for T1D. Table 10 shows the number of T1D twin pairs 
and the concordance rates by sex and zygosity. The concordance rate was notably 
higher among MZ twins than DZ twins. The crude pairwise concordance rate was 
27.3% (95% CI 22.8-31.8%) in MZ and 3.8% (95% CI 2.7-4.9%) in DZ twins.  
For the concordant pairs the twins in four MZ pairs were diagnosed within half a 
year and one pair was diagnosed on the same day. The longest discordance time was 
6.9 years. The median discordance time was 2.0 years for MZ twins and 6.0 years 
for DZ twins. A higher risk of progression to T1D was observed for the MZ co-twin 
in the survival analysis if the index twin had been diagnosed with diabetes at the age 
of 10 years under than if the index twin had been diagnosed later (p=0.06, log-rank 
test). Half of the co-twins in whom the MZ index twin had been diagnosed with T1D 
at the age of 10 years or under were predicted to develop diabetes within 7 years 
compared to 23% of those with the index twin diagnosed >10 years.  
Table 11 summarizes the results of the model fitting procedures. A model with only 
environmental effects (CE) fitted the data poorly. A model including additive 
genetic effects and non-shared environmental effects (AE) fitted best with a 
heritability estimate of 88%. A model that also included shared environmental 
effects (ACE) fitted second best (AIC=-3.23, p=0.43), with the same estimates as in 
the AE- model.  
The striking correlation with age at onset among the concordant MZ twin pairs was 
evident throughout the age range, r=0.95 (p<0.001), but it was much lower among 
the concordant DZ pairs, r=0.38 (p=0.41).  
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Table 10. Number of concordant and discordant twin pairs and crude concordance 
rates for T1D in Finnish Young Twin Cohort                                                                                           
Gender Zygosity Concordant  
pairs (n) 
Discordant 
pairs (n) 
    CONCORDANCE   RATE % 
Paiwise                     Probandwise 
Male MZ 
DZ
7
2
19
47
27.0
4.1
42.4
7.8
Female MZ 
DZ
5
1
13
43
27.8
2.3
43.5
4.4
Opp. sex DZ 4 86 4.4 8.5 
Total* MZ 
DZ
12
7
32
176
27.3 (22.9-31.8)
3.8    (2.7-4.9) 
42.9  (26.7-59.2) 
 7.4  (2.2-12.6)
*Plus one discordant pair with unknown zygosity 
Table 11. Results from fitting threshold models to T1D data in the Finnish Young 
Cohort Twins 
MODEL                     COMPONENTS OF VARIANCE                 GOODNESS OF FIT 
 A C D E χ2 df p-value AIC 
ACE 0.88 0.00 - 0.12 2.77 3 0.43 -3.23 
AE 0.88 - - 0.12 2.77 4 0.60 -5.23
ADE 0.79 - 0.09 0.12 2.88 3 0.40 -3.20 
CE - 0.60 - 0.40 28.8 4 0.00 20.8 
A, additive genetic effects; C, shared (family) environmental effects; D, due to 
dominance; E, unshared environmental effects. The best fitting model is generally 
one with the lowest AIC-value. AIC=Akaike’s information criteria?
5.2 Sibling recurrence risk of T1D and related factors (Study II) 
The data linkage yielded a total of 715 cases with some type of diabetes among the 
siblings at risk. A total of 647 (6.4%) of the 10,168 siblings were diagnosed with 
T1D by 2001. Fifty siblings had T2D, six had gestational diabetes, and 12 had 
secondary diabetes such as steroid-induced diabetes or diabetes associated with 
Down's syndrome. The median age at diagnosis of T1D among the siblings was 15.1 
years (range 0.8-56 years). Of non-diabetic living siblings, 99% were ≥20 at the end 
of the follow-up in 2001, and all had reached ?11 years of age.   
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In the siblings, the overall cumulative risk of T1D up to ages 10, 20, 30, 40, and 50 
years was 1.5 (95% CI 1.3-1.8), 4.1 (3.7-4.4), 5.5 (5.1-5.9), 6.4 (5.9-6.8), and 6.9% 
(6.4-7.4), respectively. There was a male predominance, 57% of the siblings with 
T1D were males. Males had a greater secondary attack rate of T1D at older ages 
than females. Males and females had an equal risk through the first 14 years, after 
which the risk for males began to slightly increase compared to females. The overall 
risk ratio was 1.3 (95% CI 1.1-1.5). Risk was not affected by adjustment for other 
risk factors (Table 12). 
The risk was significantly (P<0.0001) higher in the siblings of those probands that 
had been diagnosed with T1D at four years or younger compared to the siblings in 
the families where the probands had been diagnosed at the age of 15 or more. Figure 
5A shows the Kaplan-Meier curves for T1D in the siblings stratified by age at onset 
of diabetes in the proband. The cumulative risk of T1D by age 40 for a sibling 
whose proband was diagnosed at the ages of 0-4, 5-9, 10-14, and 15 or more was 
13.2 (95% CI 11.4-14.8), 7.8 (6.9-8.8), 4.7 (4.1-5.3), and 3.4% (2.6-4.2). The T1D 
risk for the sibling was 4.1 (95% CI 3.1-5.4) times higher if the proband was 
diagnosed at four years or younger than if the proband was diagnosed at 15 years or 
more. The relative risk was even higher 4.6 after adjustment for other variables 
(Table 12). 
Figure 5B shows the cumulative risk curve stratified by the year of birth of the 
sibling. Of siblings born in 1980 or after, 11.4% (95% CI 7.4-15.2) had developed 
T1D by the age of 15, while only 5.5% (95% CI 4.1-6.8) of those who were born 
between 1970-79 and 2.7% (95% CI 2.4-3.0) of those who were born before 1970 
(p<0.0001, log-rank test) had developed T1D. SIRs were 11.0, 12.6, and 12.7 for the 
years 1965-74, 1975-84, and 1985-94, respectively.  
A significant increase in the risk of T1D with increasing maternal and paternal age 
at delivery exist (p < 0.0001, log-rank test). The RR of T1D was 1.85 (95% CI 1.35-
2.55) when maternal age at delivery over 35 years was compared with those below 
25 years. The corresponding RR comparing paternal age at delivery was 1.5 (95% 
CI 1.07-2.11). The results were not considerably affected by adjustment for the other 
risk factors, but both maternal and paternal age at delivery remained significant 
predictors.  
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Figure 5. Cumulative incidence (%) of T1D in siblings of childhood-onset T1D 
patients according to age at onset of diabetes in the index case (A) and birth 
cohort (B) 
5.3 Familial aggregation of DN (Study III) 
The probands had a mean duration of diabetes of 31.4±6.5 years, whereas diabetic 
siblings had a mean disease duration of 21.6±9.0 years. The vast majority, 97% of 
the probands had had diabetes for over 20 years and none of those alive at the end of 
the follow-up had a duration of diabetes of less than 22 years. Duration of diabetes 
among 60% of siblings was at least 20 years and among 87% of siblings it was 10 
years or more.  
By the end of 2001, during 10,913 person-years of follow-up, 323 cases of DN were 
identified, 176 among the probands (33%) and 147 among the diabetic siblings 
(24%), with a total of 274 sibling pairs affected by DN. Significant differences in the 
presence of DN were found between the groups of diabetic siblings according to the 
presence of DN in the proband. DN was present in 77 (38%) of 204 siblings of the 
probands with DN, while 70 (17%) of 409 siblings of the probands without DN had 
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also DN. ESRD was present in 46 (8.6%) probands and in 36 (5.9%) diabetic 
siblings. Ten concordant pairs for ESRD (13.9% of all sib-pairs with ESRD) existed.  
The peak incidence of DN occurred at ages of 25-29 years. After reaching the peak, 
the incidence decreased in the siblings of the probands without DN, whereas new 
DN cases continued to appear beyond these ages in the siblings of the probands with 
DN. The overall 25-year cumulative risk of DN in the siblings was 34.5% (95% CI 
31.1-37.3%). Figure 6A indicates that not only the DN status of the proband, but 
also the severity of DN in the proband significantly affected the risk of DN in the 
siblings (P < 0.0001, log-rank test). The risk of progression to DN after a 25 years 
duration of diabetes in the siblings of probands with DN, but not ESRD, was 43.2% 
(95% CI 36.9-48.8), while the risk was 24.8% (95% CI 20.9-30.0) for siblings of 
probands without DN. If the proband suffered from ESRD the corresponding risk of 
DN in the siblings was even higher, 58.0% (95% CI 51.4-63.7). The risk ratio for 
DN in the siblings of probands with DN was 2.0 (95% CI 1.3-2.9) and in the siblings 
of probands with ESRD 2.9 (95% CI 1.8-4.5) compared with the siblings of normo- 
or microalbuminuric probands. The risk ratio was 2.3 (95% CI 1.4-2.7) when 
probands with DN and ESRD were combined. 
Women tended to develop DN earlier after the onset of diabetes compared to men, 
the peak in incidence rate in women occurred five years earlier. Figure 6B shows the 
development of DN in siblings stratified by the age at the onset of diabetes. Siblings 
diagnosed with diabetes before age 5 years or at the age of 15 years or later had a 
smaller risk of developing DN than patients diagnosed at the age groups 5-9 and 10-
14 years (P = 0.001, log-rank test). The 20-year progression rate of DN for the 
siblings diagnosed with diabetes at the ages of ?4, 5-9, 10-14, and ?15 were 18.7 
(95% CI 6.8-29.0), 28.2 (21.3-34.4), 30.7 (25.3-35.7), and 15.9 (10.8-20.6), 
respectively.  
Multivariate analysis by Cox regression analysis revealed that the independent 
prognostic factors predicting DN in the siblings were DN status of the proband, sex, 
the age at onset of diabetes in the siblings and parental T2D. 
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Figure 6. (A) Cumulative incidence of DN in diabetic siblings of T1D probands 
according to the DN status of probands. DN=diabetic nephropathy, ESRD=end-
stage renal disease, DN-= DN absent; DN+=DN present, excludes ESRD. (B) 
Cumulative incidence of DN in diabetic siblings of T1D probands according to age 
at onset of diabetes in siblings 
5.4 Offspring recurrence risk of T1D (Study IV) 
A total of 259 offspring, 121 girls and 138 boys were affected with T1D by the end 
of the year 2003, of which 236 were diagnosed at the age of 14 or under. Thirteen 
(22.4%) of the 58 offspring with two T1D parents were affected. In all offspring 
with one diabetic parent, the overall cumulative incidence to develop T1D by the 
age of 15 years was 5.6% (95% CI 4.9-6.4) and by the age of 20 6.7% (95% CI 5.9-
7.5). The cumulative incidence was similar in boys and girls up to 14 years but 
started to diverge thereafter. However, the difference did not reach statistical 
significance until 20 years.  
Fathers with T1D transmitted diabetes to their offspring 1.7 times more frequently 
than mothers with T1D. This sex difference in the transmission rate manifested itself 
through the higher risk for fathers who were young when diagnosed with T1D. The 
risk of T1D in the offspring was especially high, when the father had been 
diagnosed with T1D at the age of four or under: 11.0% (95% CI 6.6-15.3) of the 
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offspring became affected during their first 10 years of life compared with only 
2.4% (95% CI 0.2-4.4) in the offspring of the T1D mothers whose age at onset of 
T1D was four years or under (Figure 7A).  A young age at onset of T1D in diabetic 
mothers did not increase the risk of T1D in the offspring (Figure 7B, Table 13).  
During 1980 to 2003 the overall incidence of T1D in the offspring showed an 
average increase of 5.3% (p<0.001) per year. In the offspring of 0-4 years at 
diagnosis the annual increase was 7.3% (p<0.001), while in the offspring aged 5-9 
and 10-14 years it was 4.7% (p=0.04) and 1.7% (p=0.5), respectively. Of the 
offspring of T1D fathers born in 1995 or after, 4.2% (95% CI 2.8-5.6) had 
developed diabetes by five years of age, whereas only 1.5% (95% CI 0.5-2.5) of 
those of T1D mothers had developed diabetes.  It took on average 17.5, 10.1, 9.1, 
and 6.8 years for the offspring born in 1985 or before, 1985-1989, 1990-1994, and 
1995 or later, respectively, to reach a 4% cumulative incidence of T1D. 
The offspring of patients with T1D had approximately a 10-fold excess risk 
compared with the T1D incidence in the general population of Finland.  SIRs in a 
five-year time periods were 9.7 (95% CI 8.5-11.0) during 1985 to 2003. In the first 
period, during 1985 to 1989, it was 7.6 (95% CI 4.9-11.3) and remained fairly stable 
during the subsequent years. 
In the multivariate analysis the sex of the diabetic parent, the age at onset of diabetes 
in the T1D parent, interaction between them, and the birth year of the offspring were 
statistically significant predictors of T1D in the offspring. 
Table 13. Multivariate Cox regression analysis for the factors influencing the risk of 
T1D in offspring of parents with T1D, final model  
OFFSPRING OF MALE PROBAND                                           OFFSPRING OF FEMALE PROBAND    
Variable RR 95% CI p-value RR 95% CI p-value 
Year of birth 
<1980
1980-89
1990-94
≥1995
1.00
1.47
1.48
2.94
-
0.94-2.28
0.91-2.41
1.71-5.03 0.001
1.00
1.87
2.97
2.21
-
1.01-3.49
1.49-5.91
0.86-5.69 0.02
Age at onset of T1D 
0-4
5-9
10-14
15-17
2.66
1.45
1.17
1.00
1.48-4.79
0.90-2.33
0.77-1.79
- 0.007
0.76
0.96
0.94
1.00
0.28-2.01
0.48-1.92
0.51-1.72
- 0.95
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Figure 7. Cumulative incidence of T1D in the offspring of childhood-onset T1D 
patients according to the age at onset of diabetes in T1D fathers (A) and the age at 
onset of diabetes in T1D mothers (B) 
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6  DISCUSSION 
6.1 Study population and methods 
The aims of the present study were to determine concordance rates of T1D in twins, 
heritability of T1D, recurrence risk of T1D in siblings and offspring of patients with 
young onset T1D, temporal changes in the risk, and the factors related to the risk. 
Furthermore, the objective was also to assess the presence of familial aggregation of 
DN and its magnitude. The indisputable strengths of this study were that the study 
used uniquely large, population-based cohorts of twins, patients with young onset 
T1D, and their first-degree relatives and therefore represents unbiased data on 
families with multiple cases of patients with T1D. Opportunities to study the 
etiology of T1D are ideal in Finland because the population is genetically 
homogenous, health care for patients with diabetes is well organized, and 
nationwide registries exist. Therefore virtually all the cases with T1D can be 
ascertained. The magnitude of familial aggregation of DN has thus far not been 
specified in a population-based cohort.  
At the time of compilation of the Young Twin Cohort the completeness of the 
ascertainment of twin pairs was very high. Especially, the younger portion of the 
cohort, twins born from the early 1970s onwards, can be regarded as virtually 
complete (218). The DERI cohort of patients with T1D diagnosed at the age of 17 or 
under is a part of the Finnish T1D register, which has been shown to have a degree 
of ascertainment of nearly 100% (222; 223). The case ascertainment of T1D subjects 
in all the studies was extremely high because of several nationwide data sources that 
were available: the CDR, the HDR and the Diabetes Register of National Public 
Health Institute. The validity of type of diabetes and the age at onset was ensured 
from the medical records.  
One minor limitation of this study was that any subjects with diabetes that had been 
diagnosed at a very young age and deceased before 1964, when the CPR was 
founded, could not be detected. Such cases must however have been very few. 
Another limitation concerns the grading of the type of diabetes. Besides secondary 
and gestational diabetes, diabetes in siblings was classified into two types, T1D and 
T2D, and recorded in the medical records by the attending physician. Some of the 
siblings had a slowly progressive form of insulin-dependence and they were initially 
treated without insulin and thus might have been considered to have latent 
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autoimmune diabetes in adults (LADA) or type 1.5 diabetes (226; 227). All cases 
with autoimmunity, however, were considered as T1D irrespective of the length of 
the pre-diabetic period, if they finally showed insulin deficiency. No complete 
agreement on whether LADA and adult onset T1D are different diseases or not 
exists yet (226; 227). The vast majority of cases in this study, were however acute 
onset and the patients required insulin immediately at diagnosis. There were 50 
cases with T2D, of which 32 had onset of diabetes at the age of 35 or under. Some 
of these cases could have been misclassified although they might later prove to be 
T1D cases. Several studies suggest the presence of a slowly progressive β-cell 
destruction in a part of patients, who were classified as T2D at diagnosis (52; 56).  
Some limitations in the classification of DN can be brought up. Cases with DN and 
the date of the diagnosis were documented from the medical records, laboratory 
sheets, death certificates, and autopsy reports as precisely as it was possible. The 
data were, however, not always very solid and thus the grading of DN could not 
always be performed adequately. One confounding factor in the classification of 
patients with DN was the use of antihypertensive medication. ACE-inhibitors 
became widely used for the treatment of microalbuminuria in the 1990s.  Most of 
the DN cases were, however, diagnosed before that. In addition, ACE-inhibitors 
were often prescribed after the diagnosis of DN and not in the microalbuminuric 
state, and there was also some variety depending on the residence of T1D patients.  
Changes in medical care practices between the earliest and the more recent cohorts 
of T1D patients also caused some non-uniformity. Overt nephropathy was detected 
by dipsticks in the oldest cohorts, whereas more recently microalbuminuria testing 
was available and the screening was more regular. Some of the patients with DN 
could only be classified based on the death certificates or autopsy reports but in 
these cases the age at onset of DN could not be defined accurately. On the other 
hand, those cases were for the most part the probands in which DN was specified 
only as present or absent, whereas the age at onset of DN was a necessary tool only 
in the siblings. The data that encompass such a long time period can naturally not be 
coherent. The vast majority of DN grading, however, can be considered accurate.  
A great effort was made to determine the zygosity of all twin pairs with T1D. Several 
sources were used and only one twin pair remained unclassified by zygosity. The 
alidity of the method used to determine zygosity has been ascertained earlier (224). 
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6.2 Heritability and concordance rate of T1D 
The estimate of heritability for T1D in this study was 88% whereas it was 74% in 
the Finnish Old Twin Cohort. The concordance rates, pairwise and probandwise, in 
the MZ twins were substantially higher in the present study than those in the Finnish 
Old Twin Cohort, 27% vs. 13% and  43% vs. 23%, respectively (124). One could 
find the observed increase in heritability of T1D and the environmental factors 
influencing the increase in incidence paradoxical. Any estimate of heritability is 
valid only in a particular population, in a particular environment, and at a particular 
time. If either the genetic or the environmental component of the variance changes, 
then the heritability changes. Greater diversity of environmental factors present in a 
population will lower an estimate of heritability, while population with a more 
homogenous environment will increase an estimate of heritability, even though the 
biological mechanism underlying the trait is identical (228).   
It is important to emphasize that heritability estimates are based on a calculation of 
the genetic variation relative to the total phenotypic variation. The calculation does 
not take into account a potential gene-environment interaction that means that 
different genotypes respond differently to the same environment. Some genotypes 
are more sensitive to changes in the environment than others. Gene-environment 
interaction, however, seems to be important in T1D. Increase in the concordance of 
T1D in the MZ twins, in the incidence of T1D in the population, and the recurrence 
risk of T1D in later cohorts of siblings and offspring all indicate the importance of 
the effects of environmental changes in genetically prone individuals and thus gene-
environmental interaction. 
If environmental conditions become equalized, the remaining variance must then 
become increasingly genetic. The development of Finland from a poor agricultural 
society into a modern welfare state has had an influence everyday life of all citizens. 
During the past decades, substantial changes have occurred everyday life towards an 
affluent Western style, as a consequence of the breakthrough of the consumer 
society, changes in nutrition, physical activity, vaccinations, personal hygiene, etc. 
Despite these changes, they have occurred coherently in the whole of the country 
and have possibly homogenized the living conditions. As a consequence 
environmental variation might be diminished. 
The increased heritability might also be interpreted as a changed penetrance of the 
diabetes susceptibility genes. Some of the earlier low risk genes may have become 
more penetrant under the changing environmental conditions. It is possible that the 
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environment that has become more conducive to the diabetes development is 
reflected in the distribution of HLA genotypes among patients diagnosed during 
different time periods. The topic on temporal changes in HLA genotype frequencies 
in patients with T1D has not been studied much. The proportion of patients carrying 
high-risk HLA-genotypes has been reported to decrease while the frequency of low 
or moderate risk HLA-genotypes has increased over the last 50 years in Finland 
(229; 230). Similar findings have been reported in a  recent study from the UK 
(231). Since T1D was, however, associated with high mortality in the earlier 
decades, the distribution of HLA haplotypes, that represent those who have 
survived, may differ from those of deceased patients. Thus those kinds of studies are 
subject to bias and interpretation should be made with caution.
6.3 Dynamic temporal changes in the recurrence risk of T1D in the 
first-degree relatives 
When a child becomes affected with T1D, a common concern for the parents is, 
what is the risk in their other children to get the same disease, or if the parent has 
T1D him/herself what is the risk to the offspring. One can wonder if a customary 
answer of a 5-6% risk is a proper answer anymore. This study clearly showed that 
the lifetime risk in the first-degree relatives is dynamic and the cumulative risk of 
T1D is considerable higher in the more recent birth cohort than it was in those who 
were born some decades ago. 
The incidence of T1D has increased during the last decades quickly and the increase 
seems to be accelerated in Finland. The increase has been about 2.4% per year, a 
turning point to an accelerated increase appears to have taken place in the beginning 
of the 1990s. Such a rapid increase highlights the importance of interaction of 
environmental factors with genetic factors, obviously affecting the penetrance of 
susceptibility genes. This study showed that the recurrence risk for T1D in siblings 
and offspring is dynamic and changes over time as does the incidence in the 
background population. Instead, the recurrence risk ratio seems to remain constant. 
The SIRs for siblings were about 12 and for offspring it was 10 and varied only 
slightly during the observation period. The cumulative incidence, however, was 
higher in the more recent birth cohorts of siblings and offspring. Siblings born 
during 1980 or later had a strikingly higher cumulative risk compared with the 
earlier birth cohorts. A cumulative risk of 4% in the offspring born in the year 1995 
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or later was reached already in 7 years, whereas such a high cumulative risk was 
reached in 17.5 years in the oldest birth cohort, offspring born in 1985 or earlier.  
Very little information is available on birth cohort effects on the recurrence risk of 
T1D in first-degree relatives in different populations. Thus it is not possible to 
compare the results between studies. The previous Finnish study on recurrence risk 
in the offspring also reported a significant birth cohort effect. Offspring born in the 
year 1976 or after had a higher cumulative risk than those born before the year 1976 
(151). If the SIR between the first-degree relatives and the background population is 
constant, irrespective of the population, and the incidence is varying then differences 
in the lifetime risk among the first-degree relatives should be seen across 
populations. Positive association between the prevalence of familial T1D and the 
population incidence of T1D was observed in the European ACE study that 
examined the hypothesis that the risk of T1D among the first-degree relatives varies 
across populations mirroring the pattern of disease incidence (232). The present 
study agrees with this pattern and showed that within one population that the 
recurrence risks in the siblings and offspring of patients with T1D changes in a 
similar manner as the changes in the incidence of the background population.  
Regardless of high recurrence risk in the first-degree relatives, the vast majority of 
them do not develop diabetes during their lifetime. A much lower concordance rate 
in MZ twins than 100% proves that individuals with an apparent genetic 
susceptibility for T1D rarely develop the clinical disease. Only 10% of individuals 
bearing the highest-risk MHC genotype, the heterozygous DQB1*0302-
DRB1*0401/ DQB1*0201-DRB1*03 genotype, develop T1D (233). Despite 
harmful effects of T1D-associated alleles they are common in many populations. For 
example, high-risk HLA-DR4 allele is quite abundant in Finnish population (234). 
Penetrance of the T1D susceptibility genes is low, typical for most diseases with 
polygenic inheritance.  
Contrary to the environmental factors as a trigger of T1D, it is also possible that the 
exposure to some environmental factors prevents an individual from developing 
T1D. In such cases T1D may  develop in a person who lacks the necessary 
protective exposure that non-affected individuals experience (235; 236). This 
pattern, known as the hygiene hypothesis, proposes that the incidence of T1D has 
risen due to a reduced stimulation of the immune system by early infections (237). It 
is assumed that something protective has been lost from the childhood environment 
over recent decades. People that are living in a cleaner environment have decreasing 
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chances of natural infections and their developing immune systems are not exposed 
to the necessary stimulation.  
The association of enteroviruses with T1D has received much attention (61; 64; 
238). Their role in the risk of T1D has been found to be paradoxical. A recent study 
suggested that the frequency of enterovirus infections has decreased during the past 
30 years in the Finnish population in parallel with the doubled incidence of T1D 
(64). Notably, a substantial decrease occurred in the 1980s and the 1990s at the time 
when the incidence of T1D in Finland increased most rapidly. An interesting 
analogy has been found between the epidemiology of poliomyelitis and T1D, named 
as the polio hypothesis (64). The epidemiological pattern where the risk of 
poliovirus induced motor-neuron damage increased when the frequency of polio 
infections started to decrease rapidly in the population could be applicable to the 
observed pattern of decrease of enterovirus infections and the increase in the 
incidence of T1D in the Finnish population. The explanation for this phenomenon 
could be that the child’s first infections are delayed and occur later in childhood 
when the protective maternal antibodies have disappeared and thus the exposure to 
enteroviruses has severe consequences, similar to poliomyelitis. The role of 
infectious diseases in general, however, in the etiology of T1D is far from clear.  
6.4 Effect of age at onset of diabetes in the proband 
The twin study, as well as the studies on recurrence risk of T1D in the sibling and the 
offspring, all confirmed a remarkable impact of the young age at onset of diabetes in 
the probands on the increased risk of T1D in their first-degree relatives. The only 
exception was the absence of this pattern in the offspring of mothers with T1D.  
A correlation between the ages at onset of diabetes among affected siblings was 
lower (r=0.30) than had been suggested earlier (141; 175; 232). Among the 
concordant DZ twins it was of the same magnitude as in the siblings (r=0.38). The 
lower correlation coefficient could be a subsequent consequence of the much longer 
follow-up time in the current study than in the other studies. A sufficiently long 
follow-up time enables a larger disease-free interval among the siblings and makes it 
possible to get a more precise estimate of the correlation between the ages at onset 
between the siblings. Contrary to DZ twins and sibling pairs, MZ twins tended to 
develop diabetes at a similar age in this study (r=0.95). This result is in full 
agreement with the observation by Fava et al. (r=0.96) (175). 
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Based on this and other studies it seems that if a MZ twin pair does not become 
concordant within a relatively short time after the diagnosis of the first affected twin 
then they do not become at all (127-129). In this study, all concordant MZ pairs 
were diagnosed within 7 years and the longest discordance time for the MZ twin 
pairs was 30 years without diabetes in the co-twin. Some observations exist, 
however, that MZ twin can still be affected after a long discordance period, even 
after 36 years (131).  
The low correlation between the onset ages in the affected siblings has been 
interpreted to indicate that non-genetic factors play an important role in 
determining the age at diagnosis of T1D. Fava et al. concluded, however, that 
the age at onset of diabetes is highly genetically determined (175). A greater 
than a two-fold difference in the correlation between DZ and MZ twins in the 
current study supports the importance of genetic effects and even suggests a 
possible non-additive genetic effect in determining the age at onset of T1D. 
6.5 Sex differences 
A sex bias in the autoimmune diseases is well-known (239). Unlike in the other 
autoimmune diseases there seems to be a male predominance in T1D (42; 46). The 
incidence of T1D shows a minor sex bias up to the puberty, but more males are 
diagnosed after that (43; 45). The reason for this is unknown. This study showed a 
striking divergence in the sex ratio in adulthood in concordance with earlier 
observations. Male excess was present in the siblings with T1D after the age of 14. 
In the offspring of patients with T1D the risk ratio was equal until the age of 14, but 
the cumulative risk of males starts to diverge from that of females after that. In both 
the siblings and the offspring the cut-off point seems to be 14 years, after which the 
sex difference becomes apparent. The reasons for the male sex bias from the puberty 
is unclear, but it has been suggested that hormonal changes during puberty might 
have an influence the immune system and thus also an effect on the risk of 
developing T1D (42).  
6.6 Differential transmission of T1D from fathers vs. mothers 
This study confirmed the sex difference in the parental-offspring transmission rate 
of T1D. It was also the first to confirm this sex difference while avoiding the sources 
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of biases. The most important strength of the study was the optimal design: 
ascertainment was done through the parents with T1D and the case ascertainment 
was virtually complete. In the past women with T1D were strongly recommended 
not to have children. Improvements in diabetes care, however, that have occurred in 
the recent decades have encouraged women with T1D to plan their pregnancies. In 
this cohort of patients with T1D, in fact more female than male probands had 
children. The average number of the offspring in the female probands with progeny 
was, however, slightly smaller than that of the male probands. The reduction of the 
fecundity in the females with T1D was only 5.6% compared with males. Taking into 
account this minor difference in the fecundity the expected ratio of the incidence of 
T1D in the offspring of the fathers and the mothers with T1D was minimal whereas 
the observed ratio was considerable higher. This study clearly showed that the 
observed sex-related preferential transmission of T1D is a reality and there must be 
other reasons than biases behind it. The excess risk in the offspring of male fathers 
with T1D manifested itself through a higher the risk the younger the father was 
when diagnosed with T1D. The risk of T1D in the offspring of the fathers with T1D 
followed the pattern of progressively increased risk the younger the proband was 
when diagnosed with T1D. Unexpectedly, this pattern was totally absent in the 
offspring of the mothers with T1D. Offspring of the mothers with T1D who were 
diagnosed at the age of four or under had in fact the lowest risk, although no 
statistically significant differences appeared in the risk according the age at onset of 
diabetes in the mothers.  
The effect of the parental age at onset of T1D on the recurrence risk of T1D in 
offspring has been reported, but only few studies have analysed the data stratifying 
the offspring data by the sex of the T1D parents. Besides, none of them have used a 
cut-off point for the parental age at onset that is comparable with the current study. 
Two earlier studies provided the first observations that young maternal age at onset 
of diabetes might have a minor impact on the recurrence risk of T1D in their 
offspring (150; 152). The study from the Joslin Diabetes Clinic reported the highest 
risk of T1D in the offspring of both fathers and mothers who developed diabetes 
before age 11. The risk difference between before and after the age of 11 was, 
however, lower in the offspring of mothers with T1D than that of fathers with T1D 
(150). Another study, however, also conducted in the Joslin Diabetes Clinic reported 
contrary results: the mothers who developed diabetes before age 8 years transmitted 
diabetes at the same rate as fathers with T1D (149). The most consistent with the 
results of the current study were provided by a Danish study. Lorenzen et al. 
reported an over two-fold increased risk of T1D in the offspring of fathers who were 
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diagnosed before the age of 17 years compared with that of older ages, but no such 
relation was found in the maternal offspring (152). 
The observed sex difference in the T1D transmission can be partly explained by a 
decreased transmission rate in mothers who have been diagnosed with diabetes at a 
very young age, but the mechanism that might be responsible for this remains 
unclear. Findings of this study suggest that genetic susceptibility to T1D might be 
modified by certain aspects of diabetic pregnancies. Fetal exposure to islet 
autoantibodies in children born to the mothers with T1D has been suggested to have 
a protective effect against future islet autoimmunity and diabetes (148; 160). 
Warram et al. suggested that if the mechanism requires exposure to a diabetic 
pregnancy, the difference in the transmission of T1D would not be seen in the 
offspring that were born before the onset of diabetes in the mother (148). A Danish 
study observed a decreased risk of T1D in the offspring of female probands 
compared to the risk in the offspring of male probands, but only if the parents had 
been diagnosed with T1D before the birth of their offspring (152). The effect might 
be genetic, however, a consequence of heterogeneity of the genetic background in 
the early-onset and late-onset T1D 
It has been shown that perinatal mortality is not responsible for the decreased risk in 
the offspring of T1D mothers (148). Meanwhile, the outcome of diabetic 
pregnancies in their very early stage could be a matter of speculation. Given the fact, 
that the rate of miscarriages among women with diabetes is much higher than that 
among the general population, the possibility of selective loss of fetuses that bear a 
high-risk HLA haplotypes associated with young onset diabetes cannot be excluded.  
Other explanations that have been put forward are a possible distortion of 
transmission from the expected segregation pattern of the diabetic haplotypes and 
genomic imprinting. Fathers have been described to transmit a certain diabetic HLA 
alleles or haplotypes more often to their offspring than mothers (162; 240). Some 
evidence of an increased transmission of a Finnish high-risk haplotype [A2, Cw1, 
B56, DR4, DQ8] was found (241), but has not been confirmed (242). The evidence 
concerning the existence of non-Mendelian inheritance of HLA alleles is conflicting 
(163; 243).
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6.7 Familial aggregation of diabetic nephropathy
The strength of this study on familial clustering of DN was that this was population-
based, free of family ascertainment bias and it was longitudinal. The study 
population included all the multiplex T1D families during the defined time period 
without prior knowledge of the DN status of the patients with T1D. Most of the 
attempts to determine the sibling recurrence risk of DN have been based on small, 
clinical-based series. This study confirmed the earlier suggestion of the existence of 
strong familial aggregation of DN. The first observations on familial clustering of 
DN was made by Seaquist et al. (201). The magnitude of familial clustering was, 
however, presumably overestimated due to the small sample size, selection bias 
toward sibling pairs that were concordant for DN and due to restriction on the 
severest form of DN. The magnitude of the risk ratio for DN in the siblings of 
patients with and without DN in this study, 2.3, was closer to the estimates of Borch-
Johnsen et al. (203) and Quinn et al. (202) that were 2.5 and 4.9, respectively.  
Familial aggregation has been shown in almost all human diseases. The familial 
aggregation is generally taken as evidence for the existence of a genetic background 
for a disease. It is also possible that clustering of strong environmental risk factors 
for a disease among family members can lead to the excess risk of a disease. Khoury 
et al., however, argued that without any genetic susceptibility, familial clustering of 
high environmental risk factors is unlikely to fully account for aggregation of a 
disease among the siblings and that genetic factors may indeed play a major role in 
causing familial clustering (244). This issue was later reviewed by Guo (245). He 
agrees with the main conclusion that remarkable familiality is basically genetic, but 
pointed out the importance to avoid ascertainment bias. Thus it seems more 
plausible that the greater environmental similarity in the siblings enhances the 
familial aggregation, but that it is not the main source.  
No data on environmental risk factors, such as smoking or dietary habits, shared by 
siblings were collected in this study. Neither were the data on glycemic control 
available. It is also sometimes difficult to say if environmental factors are in real 
terms environmental. Such a factor may be glycemic control that plays an essential 
role in the development of microvascular complications. A twin study by Snieder et 
al. revealed that there is a remarkable genetic component in the variation of HbA1c 
levels (206). There might be a potential genetic link between glycemic control and 
DN, and furthermore between DN and other features that are closely related in DN 
such as hypertension, T2D, cardiovascular diseases, and insulin resistance. 
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This study showed for the first time that the risk in the sibling was dependent on the 
severity of DN in the proband suggesting a probable genetic heterogeneity in the DN 
predisposition. The risk of DN was two times higher in the siblings of the probands 
with DN (ESRD excluded) and three times higher in the siblings of the probands 
with ESRD compared with the siblings of normo- or microalbuminuric probands.  
One of the aims of this study was to define if the pattern of progression to DN is 
different in those who were diagnosed with diabetes very young or if the pattern is 
similar in all cases and rather being related to the duration of diabetes. It has been 
speculated that the pubertal years with diabetes may have a greater impact on the 
risk of  microvascular complications and premature death than do the years before 
puberty (194; 246). Few studies have distinguished the early childhood years from 
the years during the transition from prepuberty to puberty or they have focused on 
early signs of microvascular complications.  
The risk of DN was the lowest in the patients whose diabetes was diagnosed at the 
age of four or under and in those with diabetes onset after puberty whereas the risk 
for siblings whose age of onset of diabetes was between 5 and 9 years was similar to 
the peripubertal risk. This observation is in accordance with two recently published 
population-based studies, one from Finland and another from Sweden. Both 
countries reported a reduced risk of ESRD in those who had an onset of diabetes at 
four years or under (199; 200). In addition, there are some observations that an onset 
of diabetes in the youngest age group, i.e. diagnosis of diabetes before the age of 5 
years, significantly prolonged the time to early retinopathy and microalbuminuria 
and those patients had also less hospitalizations due to DN compared with the age 
groups 5–14 (197; 217; 247; 248).  
The mechanism behind this effect of age at onset is unclear. It has been speculated 
that rapid growth and hormonal changes, and worsening glycemic control in the 
puberty may have an impact on the development of complications (249; 250). 
Children who were younger than 5 years at the onset of diabetes, however, 
experience the same hormonal changes during puberty as those diagnosed with 
diabetes later in childhood. One explanation might be that children at an early age 
have got used to better self-management than those diagnosed later. There is, 
however, no evidence that children with an early-onset diabetes can maintain better 
glycemic control during the pubertal years than those diagnosed during or shortly 
before puberty (248; 251). Hormonal changes start their influence years before 
visible pubertal changes (252; 253). Those changes that occur simultaneously with 
the onset of diabetes might have an impact on the risk of DN later in life. 
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7  SUMMARY AND CONCLUSIONS 
The present study has provided new knowledge on the T1D recurrence risk in the 
first-degree relatives and the risk factors modifying the risk.  
Study I showed that the vast majority of affected MZ twin pairs remained 
discordant. The model with additive genetic and individual environmental effects 
was the best-fitting liability model, with 88% of phenotypic variance due to additive 
genetic factors. These nationwide twin data demonstrated high genetic liability for 
T1D. The concordance rates of MZ twins were substantially higher in the Finnish 
Young Twin Cohort (probandwise 43%, pairwise 27%) than in the Old Twin Cohort 
(probandwise 23%, pairwise 13%) and actually doubled in the successive birth 
cohorts. Increased heritability over time reveals the possibility of increased 
penetrance of T1D genes. This study demonstrated that the penetrance of the 
susceptibility genes for T1D may be low, although strongly influenced by 
environmental factors. Correlation with age at onset among the concordant MZ pairs 
was very high, r=0.95, denoting short discordance time between concordant MZ 
twin pairs. 
In Study II, the cumulative incidence of T1D in the siblings of T1D patients by ages 
20, 30, 40, and 50 years was 4.1, 5.6, 6.5, and 6.9%, respectively. The age at 
diagnosis in the proband considerably influenced the risk of T1D in the siblings; if 
the proband was diagnosed at the age of 0-4, 5-9, 10-14, and 15 or more, the 
cumulative incidence of T1D in the siblings by the age of 40 was 13.2%, 7.8%, 
4.7%, and 3.4%, respectively. The brothers had a progressively higher risk of T1D 
after the age of 14 compared to the sisters. Both increasing maternal and paternal 
age at delivery were significant risk factors for T1D in the siblings. Cumulative 
incidence of T1D in the siblings increased with increasing birth year mirroring the 
incidence of T1D in the background population. Siblings born in the year 1980 or 
after had 15-year cumulative risk of 11.4%, whereas siblings born 1970-79 and 1970 
or before had 5.5% and 2.7%, respectively. SIRs among siblings aged 14 years or 
under, however, was approximately 12 throughout the follow-up.  
Study III revealed that although the majority of sibling pairs with T1D were 
discordant for DN, its presence in one sibling doubles and presence of ESRD triples 
the risk of DN in the siblings with T1D. Truly population-based studies on the 
sibling DN recurrence risk did not exist before the current study. The familial 
aggregation of DN emphasizes the involvement of a genetic component in the 
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development of DN, but shared environmental risk factors cannot be completely 
excluded in the familial clustering of DN.  
Since the incidence of T1D is increasing a greater number of patients is supposed to 
suffer from diabetic complications in the future. Because the age at onset of diabetes 
has decreased, the mean duration of diabetes will increase alike. An encouraging 
observation is that children diagnosed at the age of 4 or earlier seem to have a 
decreased risk of DN or they have at least a delayed onset of DN and may develop 
DN rather at the same age than after the same duration of diabetes than those with 
diabetes diagnosed at a later stage. 
Study IV provided epidemiological evidence of sex-related preferential transmission 
of T1D. Offspring of fathers with T1D had 1.7 times higher risk to be affected than 
offspring of mothers with T1D. It was mediated by the different effect of the age at 
onset of diabetes in the fathers and mothers. A young age at onset of diabetes in the 
fathers with T1D increased the risk of T1D in the offspring, but such a pattern was 
not seen in the offspring of T1D mothers. This result reinforces the possibility that 
genetic susceptibility to T1D might be modified somehow in diabetic pregnancies. 
This study also indicated that the incidence in the offspring of T1D patients was 10 
times higher than that in the general population. 
This study revealed dynamic temporal changes in the recurrence risk of T1D in the 
first-degree relatives. The increase of the incidence in the first-degree relatives 
seemed to follow that of the background population: SIRs between the siblings of 
patients with T1D and the background population was fairly constant throughout the 
follow-up as well as between the offspring and the background population.  
This study provides new knowledge on etiology of T1D and DN. The final goal in 
the research objectives is to achieve the prevention or cure T1D and its 
complications and it is possible only with good understanding of the etiology as well 
as the natural progression of the diseases.
74
8  ACKNOWLEDGEMENTS 
This work was carried out at the Diabetes Unit of the Department of Health Promotion 
and Chronic Disease Prevention, National Public Health Institute (KTL). I wish to 
thank the KTL and especially the Diabetes Unit for providing excellent research 
facilities for this work. 
I express my deepest gratitude to my supervisor, Professor Jaakko Tuomilehto. I am 
grateful to him for introducing me to the exciting and complex field of diabetes. I 
especially value that Jaakko has trusted me from the very beginning and given me 
freedom and responsibility in my work. For Jaakko it was crystal-clear after the 
completion of my Master’s work that I would go on doing the PhD thesis - something 
that became fully clear to me only just when I was writing the summary for the thesis.  I 
am grateful to Professor Jaakko Kaprio for the opportunity to use the valuable data on 
the Finnish Young Twin Cohort for this thesis and his guidance in the twin research 
methodology.  
My sincere gratitude goes to the official reviewers of this thesis, Docent Per-Henrik 
Groop and Professor Juni Palmgren. Their critical revision and constructive comments 
helped to improve the manuscript remarkably. I am especially grateful to Per-Henrik 
Groop who put his time and effort into the linguistic revision of this thesis. 
I am grateful to all the co-authors for sharing their time and expertise. I thank all the 
study subjects for participating in the twin study. I am grateful also to the personnel 
in the archives of the hospitals and medical centres who sought out the medical 
records, copied and sent them to me. 
It has been a great pleasure to work in the Diabetes Unit with numerous colleagues over 
these years and I want to thank all of them for their positive support, help and friendship. 
This study was financially supported by the Doctoral Programs in Public Health, 
the Academy of Finland, the Juvenile Diabetes Research Foundation 
International, the Sigrid Jusélius Foundation and the Finnish Kidney Foundation. 
They are all gratefully acknowledged.  
Helsinki, November 2006 
Valma Harjutsalo 
75
9  REFERENCES 
1. Khoury M, Beaty T, Cohen B: Fundamentals of genetic epidemilogy. New York, Oxford 
University Press, 1993 
2. Burton PR, Tobin MD: Epidemiology and Genetic Epidemiology, John Wiley & Sons Ltd., 2003 
3. Zhao LP, Hsu L, Davidov O, Potter J, Elston RC, Prentice RL: Population-based family study 
designs: an interdisciplinary research framework for genetic epidemiology. Genet Epidemiol
14:365-388, 1997 
4. Risch N: Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum 
Genet 46:222-228, 1990 
5. Hartl DL, Clark AG: Principles of Population Genetics, Pennsylvania State University, 1997 
6. Weiss K: Genetic variation and human diseases: principles and evolutionary approaches.
Cambridge, The Press Syndicate of the University of Cambridge, 1993 
7. Galton F: The history of twins, as a criterion of the relative powers of nature and nurture. J
Anthropol Inst. 12:566-576, 1875 
8. Boomsma D, Busjahn A, Peltonen L: Classical twin studies and beyond. Nat Rev Genet 3:872-
882, 2002 
9. Guo SW: Does higher concordance in monozygotic twins than in dizygotic twins suggest a 
genetic component? Hum Hered 51:121-132, 2001 
10. Smith C: Concordance in twins: methods and interpretation. Am J Hum Genet 26:454-466, 1974 
11. Witte JS, Carlin JB, Hopper JL: Likelihood-based approach to estimating twin concordance for 
dichotomous traits. Genet Epidemiol 16:290-304, 1999 
12. Falconer D, MacKay T: Introduction to quantitative genetics. New York, Addison-Wesley, 1995 
13. Neale M, Cardon L: Methodology for Genetic Studies of Twins and Families. Dordrecht, 
Kluwer Academic, 1992 
14. Rewers M, LaPorte RE, King H, Tuomilehto J: Trends in the prevalence and incidence of 
diabetes: insulin-dependent diabetes mellitus in childhood. World Health Stat Q 41:179-189, 1988 
15. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its 
complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a 
WHO consultation. Diabet Med 15:539-553, 1998 
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the 
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care
20:1183-1197, 1997 
17. Lipton R, LaPorte RE: Epidemiology of islet cell antibodies. Epidemiol Rev 11:182-203, 1989 
18. Singal DP, Blajchman MA: Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies 
and tissue antibodies in patients with diabetes mellitus. Diabetes 22:429-432, 1973 
76
19. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Nielsen LS, 
Thomsen M, Svejgaard A: HL-A antigens and diabetes mellitus. Lancet 2:864-866, 1974 
20. Cudworth AG, Woodrow JC: Evidence for HL-A-linked genes in "juvenile" diabetes mellitus. 
Br Med J 3:133-135, 1975 
21. Klein J, Sato A: The HLA system. Second of two parts. N Engl J Med 343:782-786, 2000 
22. Klein J, Sato A: The HLA system. First of two parts. N Engl J Med 343:702-709, 2000 
23. Pugliese A, Eisenbarth GS: Type I Diabetes Mellitus of Man: Genetic Susceptibility and 
Resistance. In Type 1 Diabetes: Molecular, Cellular, and Clinical Immunology, Kluwer 
Academic/Plenum Publishers, 2006 
24. Pociot F, McDermott MF: Genetics of type 1 diabetes mellitus. Genes Immun 3:235-249, 2002 
25. Cavender D, Orchard TJ, Wagener D, LaPorte RE, Rabin B, Eberhardt M: The development of 
type 1 diabetes in HLA identical siblings of type 1 diabetic patients: associations with specific 
HLA antigens]. Diabetologia 23:379, 1982 
26. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EA: Predicting 
insulin-dependent diabetes. Lancet 1:845-850, 1988 
27. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, Stirling B, Mitra 
M, Farmer J, Williams SR, Cox NJ, Bell GI, Risch N, Spielman RS: A second-generation screen 
of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 19:292-
296, 1998 
28. Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, Goy JV, Smith AN, Sebag-
Montefiore L, Merriman ME, Wilson AJ, Pritchard LE, Cucca F, Barnett AH, Bain SC, Todd JA: 
A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet
19:297-300, 1998 
29. Nerup J, Pociot F: A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: 
identification of new loci with evidence of interactions. Am J Hum Genet 69:1301-1313, 2001 
30. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, 
Concannon P: Seven regions of the genome show evidence of linkage to type 1 diabetes in a 
consensus analysis of 767 multiplex families. Am J Hum Genet 69:820-830, 2001 
31. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS: Type 1 
diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex 
families. Diabetes 54:2995-3001, 2005 
32. Redondo MJ, Fain PR, Eisenbarth GS: Genetics of type 1A diabetes. Recent Prog Horm Res
56:69-89, 2001 
33. Hirschhorn JN: Genetic epidemiology of type 1 diabetes. Pediatr Diabetes 4:87-100, 2003 
34. Diabetes Epidemiology Research International Group: Geographic patterns of childhood 
insulin-dependent diabetes mellitus. Diabetes 37:1113-1119, 1988 
77
35. Karvonen M, Tuomilehto J, Libman I, LaPorte R: A review of the recent epidemiological data 
on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health 
Organization DIAMOND Project Group. Diabetologia 36:883-892, 1993 
36. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J: Incidence 
of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes
Care 23:1516-1526, 2000 
37. Ronningen KS, Keiding N, Green A: Correlations between the incidence of childhood-onset 
type I diabetes in Europe and HLA genotypes. Diabetologia 44 Suppl 3:B51-59, 2001 
38. Tuomilehto J, Podar T, Brigis G, Urbonaite B, Rewers M, Adojaan B, Cepaitis Z, Kalits I, 
King H, LaPorte R, et al.: Comparison of the incidence of insulin-dependent diabetes mellitus in 
childhood among five Baltic populations during 1983-1988. Int J Epidemiol 21:518-527, 1992 
39. Podar T, Solntsev A, Karvonen M, Padaiga Z, Brigis G, Urbonaite B, Viik-Kajander M, 
Reunanen A, Tuomilehto J: Increasing incidence of childhood-onset type I diabetes in 3 Baltic 
countries and Finland 1983-1998. Diabetologia 44 Suppl 3:B17-20, 2001 
40. Kondrashova A, Reunanen A, Romanov A, Karvonen A, Viskari H, Vesikari T, Ilonen J, Knip 
M, Hyöty H: A six-fold gradient in the incidence of type 1 diabetes at the eastern border of 
Finland. Ann Med 37:67-72, 2005 
41. Carle F, Gesuita R, Bruno G, Coppa GV, Falorni A, Lorini R, Martinucci ME, Pozzilli P, 
Prisco F, Songini M, Tenconi MT, Cherubini V: Diabetes incidence in 0- to 14-year age-group in 
Italy: a 10-year prospective study. Diabetes Care 27:2790-2796, 2004 
42. Gale EA, Gillespie KM: Diabetes and gender. Diabetologia 44:3-15, 2001 
43. Nyström L, Dahlquist G, Ostman J, Wall S, Arnqvist H, Blohme G, Lithner F, Littorin B, 
Schersten B, Wibell L: Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 
years of age: indications of climatological determinants for age at onset. Int J Epidemiol 21:352-
358, 1992 
44. Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, 
Gorus FK: Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. 
Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% 
ascertainment. The Belgian Diabetes Registry. Diabetes Care 20:1556-1561, 1997 
45. Gavard JA, Dorman JS, LaPorte RE, Orchard TJ, Drash AL, Trucco MM, Kelsey SF, Kostraba 
JN, Becker DJ: Sex differences in secondary attack rate of IDDM to siblings of probands through 
older ages. Pittsburgh Etiology of IDDM Study. Diabetes Care 15:559-561, 1992 
46. Karvonen M, Pitkäniemi M, Pitkäniemi J, Kohtamäki K, Tajima N, Tuomilehto J: Sex 
difference in the incidence of insulin-dependent diabetes mellitus: an analysis of the recent 
epidemiological data. World Health Organization DIAMOND Project Group. Diabetes Metab Rev
13:275-291, 1997 
47. Karvonen M, Pitkäniemi J, Tuomilehto J: The onset age of type 1 diabetes in Finnish children 
has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 22:1066-
1070, 1999 
78
48. Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EA: Rising incidence of insulin 
dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The 
Bart's-Oxford Study Group. Bmj 315:713-717, 1997 
49. Green A, Patterson CC: Trends in the incidence of childhood-onset diabetes in Europe 1989-
1998. Diabetologia 44 Suppl 3:B3-8, 2001 
50. Feltbower RG, McKinney PA, Parslow RC, Stephenson CR, Bodansky HJ: Type 1 diabetes in 
Yorkshire, UK: time trends in 0-14 and 15-29-year-olds, age at onset and age-period-cohort 
modelling. Diabet Med 20:437-441, 2003 
51. Charkaluk ML, Czernichow P, Levy-Marchal C: Incidence data of childhood-onset type I 
diabetes in France during 1988-1997: the case for a shift toward younger age at onset. Pediatr Res
52:859-862, 2002 
52. Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, 
Turner R: Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is 
influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study 
(UKPDS) Group. Diabetologia 42:608-616, 1999 
53. Gillespie KM, Gale EA, Bingley PJ: High familial risk and genetic susceptibility in early onset 
childhood diabetes. Diabetes 51:210-214, 2002 
54. Tuomilehto-Wolf E, Tuomilehto J: Is the high incidence of diabetes in young children 
diagnosed under the age of 4 years determined by genetic factors in Finland? The DIME Study 
Group. Diabete Metab 19:167-172, 1993 
55. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougneres P, 
Bach JF: Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. 
J Clin Invest 90:2242-2250, 1992 
56. Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler 
UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA: Immunological heterogeneity in type I 
diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly 
progressive disease. Diabetologia 41:891-897, 1998 
57. Karvonen M, Jäntti V, Muntoni S, Stabilini M, Stabilini L, Tuomilehto J: Comparison of the 
seasonal pattern in the clinical onset of IDDM in Finland and Sardinia. Diabetes Care 21:1101-
1109, 1998 
58. Padaiga Z, Tuomilehto J, Karvonen M, Dahlquist G, Podar T, Adojaan B, Urbonaite B, 
Zalinkevicius R, Brigis G, Virtala E, Kohtamäki K, Cepaitis Z, Tuomilehto-Wolf E: Seasonal 
variation in the incidence of Type 1 diabetes mellitus during 1983 to 1992 in the countries around 
the Baltic Sea. Diabet Med 16:736-743, 1999 
59. Laron Z: Incidence and seasonality of type 1 diabetes mellitus--what now? J Pediatr 
Endocrinol Metab 15:573-575, 2002 
60. Durruty P, Ruiz F, Garcia de los Rios M: Age at diagnosis and seasonal variation in the onset 
of insulin-dependent diabetes in Chile (Southern hemisphere). Diabetologia 17:357-360, 1979 
61. Hyöty H: Enterovirus infections and type 1 diabetes. Ann Med 34:138-147, 2002 
79
62. Haverkos HW, Battula N, Drotman DP, Rennert OM: Enteroviruses and type 1 diabetes 
mellitus. Biomed Pharmacother 57:379-385, 2003 
63. Kimpimäki T, Kupila A, Hämäläinen AM, Kukko M, Kulmala P, Savola K, Simell T, 
Keskinen P, Ilonen J, Simell O, Knip M: The first signs of beta-cell autoimmunity appear in 
infancy in genetically susceptible children from the general population: the Finnish Type 1 
Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 86:4782-4788, 2001 
64. Viskari HR, Koskela P, Lönnrot M, Luonuansuu S, Reunanen A, Baer M, Hyöty H: Can 
enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 23:414-
416, 2000 
65. Jun HS, Yoon JW: A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 19:8-31, 2003 
66. Hyöty H, Taylor KW: The role of viruses in human diabetes. Diabetologia 45:1353-1361, 2002 
67. Gamble DR: Relation of antecedent illness to development of diabetes in children. Br Med J
281:99-101, 1980 
68. Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, Åkerblom HK: Environmental triggers 
and determinants of type 1 diabetes. Diabetes 54 Suppl 2:S125-136, 2005 
69. Schattner A: Consequence or coincidence? The occurrence, pathogenesis and significance of 
autoimmune manifestations after viral vaccines. Vaccine 23:3876-3886, 2005 
70. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M: Childhood vaccination and type 1 diabetes. N
Engl J Med 350:1398-1404, 2004 
71. Classen JB, Classen DC: Clustering of cases of type 1 diabetes mellitus occurring 2-4 years 
after vaccination is consistent with clustering after infections and progression to type 1 diabetes 
mellitus in autoantibody positive individuals. J Pediatr Endocrinol Metab 16:495-508, 2003 
72. Karvonen M, Cepaitis Z, Tuomilehto J: Association between type 1 diabetes and Haemophilus 
influenzae type b vaccination: birth cohort study. Bmj 318:1169-1172, 1999 
73. Haglund B, Ryckenberg K, Selinus O, Dahlquist G: Evidence of a relationship between 
childhood-onset type I diabetes and low groundwater concentration of zinc. Diabetes Care 19:873-
875, 1996 
74. Virtanen SM, Jaakkola L, Räsänen L, Ylönen K, Aro A, Lounamaa R, Åkerblom HK, 
Tuomilehto J: Nitrate and nitrite intake and the risk for type 1 diabetes in Finnish children. 
Childhood Diabetes in Finland Study Group. Diabet Med 11:656-662, 1994 
75. Virtanen SM, Knip M: Nutritional risk predictors of beta cell autoimmunity and type 1 
diabetes at a young age. Am J Clin Nutr 78:1053-1067, 2003 
76. Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup 
K, Nerup J: Relation between breast-feeding and incidence rates of insulin-dependent diabetes 
mellitus. A hypothesis. Lancet 2:1083-1086, 1984 
77. Atkinson MA, Ellis TM: Infants diets and insulin-dependent diabetes: evaluating the "cows' milk 
hypothesis" and a role for anti-bovine serum albumin immunity. J Am Coll Nutr 16:334-340, 1997 
80
78. Couper JJ, Steele C, Beresford S, Powell T, McCaul K, Pollard A, Gellert S, Tait B, Harrison 
LC, Colman PG: Lack of association between duration of breast-feeding or introduction of cow's 
milk and development of islet autoimmunity. Diabetes 48:2145-2149, 1999 
79. The EURODIAB Substudy 2 Study Group: Vitamin D supplement in early childhood and risk 
for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42:51-54, 1999 
80. Hyppönen E, Läära E, Reunanen A, Järvelin MR, Virtanen SM: Intake of vitamin D and risk 
of type 1 diabetes: a birth-cohort study. Lancet 358:1500-1503, 2001 
81. Stene LC, Ulriksen J, Magnus P, Joner G: Use of cod liver oil during pregnancy associated 
with lower risk of Type I diabetes in the offspring. Diabetologia 43:1093-1098, 2000 
82. Stene LC, Joner G: Use of cod liver oil during the first year of life is associated with lower risk 
of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr
78:1128-1134, 2003 
83. Longnecker MP, Daniels JL: Environmental contaminants as etiologic factors for diabetes. 
Environ Health Perspect 109 Suppl 6:871-876, 2001 
84. Kostraba JN, Gay EC, Rewers M, Hamman RF: Nitrate levels in community drinking waters 
and risk of IDDM. An ecological analysis. Diabetes Care 15:1505-1508, 1992 
85. Moltchanova E, Rytkönen M, Kousa A, Taskinen O, Tuomilehto J, Karvonen M: Zinc and 
nitrate in the ground water and the incidence of Type 1 diabetes in Finland. Diabet Med 21:256-
261, 2004 
86. Parslow RC, McKinney PA, Law GR, Staines A, Williams R, Bodansky HJ: Incidence of 
childhood diabetes mellitus in Yorkshire, northern England, is associated with nitrate in drinking 
water: an ecological analysis. Diabetologia 40:550-556, 1997 
87. Van Maanen JM, Albering HJ, Van Breda SG, Curfs DM, Ambergen AW, Wolffenbuttel BH, 
Kleinjans JC, Reeser HM: Nitrate in drinking water and risk of childhood diabetes in The 
Netherlands. Diabetes Care 22:1750, 1999 
88. Myers MA, Hettiarachchi KD, Ludeman JP, Wilson AJ, Wilson CR, Zimmet PZ: Dietary 
microbial toxins and type 1 diabetes. Ann N Y Acad Sci 1005:418-422, 2003 
89. Kilkkinen A, Virtanen SM, Klaukka T, Kenward MG, Salkinoja-Salonen M, Gissler M, Kaila 
M, Reunanen A: Use of antimicrobials and risk of type 1 diabetes in a population-based mother-
child cohort. Diabetologia 49:66-70, 2006 
90. Bingley PJ, Douek IF, Rogers CA, Gale EA: Influence of maternal age at delivery and birth 
order on risk of type 1 diabetes in childhood: prospective population based family study. Bart's-
Oxford Family Study Group. Bmj 321:420-424, 2000 
91. Stene LC, Magnus P, Lie RT, Sovik O, Joner G: Maternal and paternal age at delivery, birth 
order, and risk of childhood onset type 1 diabetes: population based cohort study. Bmj 323:369, 2001 
92. Dahlquist G, Bennich SS, Kallen B: Intrauterine growth pattern and risk of childhood onset 
insulin dependent (type I) diabetes: population based case-control study. Bmj 313:1174-1177, 1996 
81
93. Larsson K, Elding-Larsson H, Cederwall E, Kockum K, Neiderud J, Sjöblad S, Lindberg B, 
Lernmark B, Cilio C, Ivarsson SA, Lernmark A: Genetic and perinatal factors as risk for childhood 
type 1 diabetes. Diabetes Metab Res Rev 20:429-437, 2004 
94. Dahlquist GG, Patterson C, Soltesz G: Perinatal risk factors for childhood type 1 diabetes in 
Europe. The EURODIAB Substudy 2 Study Group. Diabetes Care 22:1698-1702, 1999 
95. Cardwell CR, Carson DJ, Patterson CC: Parental age at delivery, birth order, birth weight and 
gestational age are associated with the risk of childhood Type 1 diabetes: a UK regional 
retrospective cohort study. Diabet Med 22:200-206, 2005 
96. Flood TM, Brink SJ, Gleason RE: Increased incidence of type I diabetes in children of older 
mothers. Diabetes Care 5:571-573, 1982 
97. Wagener DK, LaPorte RE, Orchard TJ, Cavender D, Kuller LH, Drash AL: The Pittsburgh 
diabetes mellitus study. 3: An increased prevalence with older maternal age. Diabetologia 25:82-
85, 1983 
98. Podar T, Onkamo P, Forsén T, Karvonen M, Tuomilehto-Wolf E, Tuomilehto J: Neonatal 
anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. 
Diabetes Care 22:2092-2094, 1999 
99. Stene LC, Magnus P, Lie RT, Sovik O, Joner G: Birth weight and childhood onset type 1 
diabetes: population based cohort study. Bmj 322:889-892, 2001 
100. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE, Couper JJ, 
Tait BD, Colman PG, Harrison LC: Association between rotavirus infection and pancreatic islet 
autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49:1319-1324, 2000 
101. Tuomilehto J, Karvonen M, Pitkäniemi J, Virtala E, Kohtamäki K, Toivanen L, Tuomilehto-
Wolf E: Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children. 
The Finnish Childhood Type I Diabetes Registry Group. Diabetologia 42:655-660, 1999 
102. Rytkönen M, Moltchanova E, Ranta J, Taskinen O, Tuomilehto J, Karvonen M: The 
incidence of type 1 diabetes among children in Finland--rural-urban difference. Health Place
9:315-325, 2003 
103. Siren MK, Sareneva H, Lokki ML, Koskimies S: Unique HLA antigen frequencies in the 
Finnish population. Tissue Antigens 48:703-707, 1996 
104. Kukko M, Virtanen SM, Toivonen A, Simell S, Korhonen S, Ilonen J, Simel O, Knip M: 
Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell 
autoimmunity in a high-incidence country. Diabetes Care 27:676-681, 2004 
105. Harris H: The familial distribution of diabetes mellitus: a study of the relatives of 1241 
diabetic propositi. Annals of Eugenics 15:95-119, 1950 
106. Pincus G, White P: The inheritance of diabetes mellitus. II. Further analysis of family 
histories. Am J Med Sci 188:159-168, 1934 
107. Pincus G, White P: On the heritance of diabetes mellitus. I. An analysis of 675 family 
histories. Am J Med Sci 186:1-14, 1933 
82
108. Steinberg AG, Wilder RM: A study of the genetics of diabetes mellitus. Am J Hum Genet
4:113-135, 1952 
109. Barrai I, Cann HM: Segregation Analysis of Juvenile Diabetes Mellitus. J Med Genet 42:8-
11, 1965 
110. Smith C, Falconer DS, Duncan LJ: A statistical and genetical study of diabetes. II. 
Heritability of liability. Ann Hum Genet 35:281-299, 1972 
111. Falconer DS: The inheritance of liability to diseases with variable age of onset, with 
particular reference to diabetes mellitus. Ann Hum Genet 31:1-20, 1967 
112. Simpson NE: Diabetes in the families of diabetics. Can Med Assoc J 98:427-432, 1968 
113. Thompson GS: Genetic factors in diabetes mellitus studied by the oral glucose tolerance test. 
J Med Genet 2:221-226, 1965 
114. WHO Expert Committee: WHO Expert Committee on Diabetes Mellitus: second report. 
World Health Organ Tech Rep Ser 646:1-80, 1980 
115. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other 
categories of glucose intolerance. Diabetes 28:1039-1057, 1979 
116. Darlow JM, Smith C, Duncan LJ: A statistical and genetical study of diabetes. 3. Empiric 
risks to relatives. Ann Hum Genet 37:157-174, 1973 
117. Harvald B, Hauge M: Selection in diabetes in modern society. Acta Med Scand 173:459-465, 1963 
118. Gottlieb MS, Root HF: Diabetes mellitus in twins. Diabetes 17:693-704, 1968 
119. Pollin W, Allen MG, Hoffer A, Stabenau JR, Hrubec Z: Psychopathology in 15,909 pairs of 
veteran twins: evidence for a genetic factor in the pathogenesis of schizophrenia and its relative 
absence in psychoneurosis. Am J Psychiatry 126:597-610, 1969 
120. Tattersall RB, Pyke DA: Diabetes in identical twins. Lancet 2:1120-1125, 1972 
121. Kumar D, Gemayel NS, Gill SK, Bray GA, Roy-Burman P, Deapen D, Mack TM: Type-
specific concordance in young diabetic monozygotic twins. Adv Exp Med Biol 246:259-267, 1988 
122. Barnett AH, Eff C, Leslie RD, Pyke DA: Diabetes in identical twins. A study of 200 pairs. 
Diabetologia 20:87-93, 1981 
123. Committee on Diabetic Twins JDS: Diabetes mellitus in twins: a cooperative study in Japan. 
Diabetes Res Clin Pract 5:271-280, 1988 
124. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengård J, 
Kesäniemi YA: Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) 
diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060-1067, 1992 
125. Kyvik KO, Green A, Beck-Nielsen H: Concordance rates of insulin dependent diabetes 
mellitus: a population based study of young Danish twins. Bmj 311:913-917, 1995 
126. Johnston C, Pyke DA, Cudworth AG, Wolf E: HLA-DR typing in identical twins with 
insulin-dependent diabetes: difference between concordant and discordant pairs. Br Med J (Clin 
Res Ed) 286:253-255, 1983 
83
127. Olmos P, A'Hern R, Heaton DA, Millward BA, Risley D, Pyke DA, Leslie RD: The 
significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. 
Diabetologia 31:747-750, 1988 
128. Kumar D, Gemayel NS, Deapen D, Kapadia D, Yamashita PH, Lee M, Dwyer JH, Roy-
Burman P, Bray GA, Mack TM: North-American twins with IDDM. Genetic, etiological, and 
clinical significance of disease concordance according to age, zygosity, and the interval after 
diagnosis in first twin. Diabetes 42:1351-1363, 1993 
129. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, Leslie RD: 
Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United 
States. Diabetologia 44:354-362, 2001 
130. Metcalfe KA, Hitman GA, Rowe RE, Hawa M, Huang X, Stewart T, Leslie RD: 
Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care
24:838-842, 2001 
131. Verge CF, Gianani R, Yu L, Pietropaolo M, Smith T, Jackson RA, Soeldner JS, Eisenbarth 
GS: Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical 
twins of patients with type I diabetes. Diabetes 44:1176-1179, 1995 
132. Degnbol B, Green A: Diabetes mellitus among first- and second-degree relatives of early 
onset diabetics. Ann Hum Genet 42:25-47, 1978 
133. West R, Belmonte MM, Colle E, Crepeau MP, Wilkins J, Poirier R: Epidemiologic survey of 
juvenile-onset diabetes in Montreal. Diabetes 28:690-693, 1979 
134. Gottlieb MS: Diabetes in offspring and siblings of juvenile- and maturity-onset-type 
diabetics. J Chronic Dis 33:331-339, 1980 
135. Gamble DR: An epidemiological study of childhood diabetes affecting two or more siblings. 
Diabetologia 19:341-344, 1980 
136. Chern MM, Anderson VE, Barbosa J: Empirical risk for insulin-dependent diabetes (IDD) in 
sibs. Further definition of genetic heterogeneity. Diabetes 31:1115-1118, 1982 
137. Wagener DK, Sacks JM, LaPorte RE, Macgregor JM: The Pittsburgh study of insulin-dependent 
diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 31:136-144, 1982 
138. Tillil H, Kobberling J: Age-corrected empirical genetic risk estimates for first-degree 
relatives of IDDM patients. Diabetes 36:93-99, 1987 
139. Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandström A, Wall S: The Swedish childhood 
diabetes study--results from a nine year case register and a one year case-referent study indicating 
that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-
dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32:2-6, 1989 
140. Allen C, Palta M, D'Alessio DJ: Risk of diabetes in siblings and other relatives of IDDM 
subjects. Diabetes 40:831-836, 1991 
141. Pociot F, Norgaard K, Hobolth N, Andersen O, Nerup J: A nationwide population-based 
study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark. 
Danish Study Group of Diabetes in Childhood. Diabetologia 36:870-875, 1993 
84
142. Lorenzen T, Pociot F, Hougaard P, Nerup J: Long-term risk of IDDM in first-degree relatives 
of patients with IDDM. Diabetologia 37:321-327, 1994 
143. Steck AK, Barriga KJ, Emery LM, Fiallo-Scharer RV, Gottlieb PA, Rewers MJ: Secondary 
attack rate of type 1 diabetes in Colorado families. Diabetes Care 28:296-300, 2005 
144. Dahlquist G, Gustavsson KH, Holmgren G, Hagglof B, Larsson Y, Nilsson KO, Samuelsson 
G, Sterky G, Thalme B, Wall S: The incidence of diabetes mellitus in Swedish children 0-14 years 
of age. A prospective study 1977-1980. Acta Paediatr Scand 71:7-14, 1982 
145. O'Leary LA, Dorman JS, LaPorte RE, Orchard TJ, Becker DJ, Kuller LH, Eberhardt MS, 
Cavender DE, Rabin BS, Drash AL: Familial and sporadic insulin-dependent diabetes: evidence 
for heterogeneous etiologies? Diabetes Res Clin Pract 14:183-190, 1991 
146. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, 
Åkerblom HK: Epidemiology of childhood diabetes mellitus in Finland--background of a 
nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in 
Finland (DiMe) Study Group. Diabetologia 35:70-76, 1992 
147. Metcalfe MA, Baum JD: Family characteristics and insulin dependent diabetes. Arch Dis 
Child 67:731-736, 1992 
148. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR: Differences in risk of insulin-dependent 
diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311:149-152, 1984 
149. Bleich D, Polak M, Eisenbarth GS, Jackson RA: Decreased risk of type I diabetes in offspring 
of mothers who acquire diabetes during adrenarchy. Diabetes 42:1433-1439, 1993 
150. el-Hashimy M, Angelico MC, Martin BC, Krolewski AS, Warram JH: Factors modifying the 
risk of IDDM in offspring of an IDDM parent. Diabetes 44:295-299, 1995 
151. Tuomilehto J, Podar T, Tuomilehto-Wolf E, Virtala E: Evidence for importance of gender 
and birth cohort for risk of IDDM in offspring of IDDM parents. Diabetologia 38:975-982, 1995 
152. Lorenzen T, Pociot F, Stilgren L, Kristiansen OP, Johannesen J, Olsen PB, Walmar A, Larsen 
A, Albrechtsen NC, Eskildsen PC, Andersen OO, Nerup J: Predictors of IDDM recurrence risk in 
offspring of Danish IDDM patients. Danish IDDM Epidemiology and Genetics Group. 
Diabetologia 41:666-673, 1998 
153. EURODIAB ACE Study Group: Familial risk of type I diabetes in European children. 
Diabetologia 41:1151-1156, 1998 
154. Miodovnik M, Lavin JP, Knowles HC, Holroyde J, Stys SJ: Spontaneous abortion among 
insulin-dependent diabetic women. Am J Obstet Gynecol 150:372-376, 1984 
155. Dorman JS, Burke JP, McCarthy BJ, Norris JM, Steenkiste AR, Aarons JH, Schmeltz R, 
Cruickshanks KJ: Temporal trends in spontaneous abortion associated with Type 1 diabetes. 
Diabetes Res Clin Pract 43:41-47, 1999 
156. Lorenzen T, Pociot F, Johannesen J, Kristiansen OP, Nerup J: A population-based survey of 
frequencies of self-reported spontaneous and induced abortions in Danish women with Type 1 
diabetes mellitus. Danish IDDM Epidemiology and Genetics Group. Diabet Med 16:472-476, 1999 
85
157. Penney GC, Mair G, Pearson DW: Outcomes of pregnancies in women with type 1 diabetes 
in Scotland: a national population-based study. Bjog 110:315-318, 2003 
158. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA: Glycemic thresholds for 
spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet
Gynecol 84:515-520, 1994 
159. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS: First-trimester hemoglobin 
A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology
39:225-231, 1989 
160. Koczwara K, Bonifacio E, Ziegler AG: Transmission of maternal islet antibodies and risk of 
autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53:1-4, 2004 
161. Buschard K, Jorgensen M, Aaen K, Bock T, Josefsen K: Prevention of diabetes mellitus in 
BB rats by neonatal stimulation of beta cells. Lancet 335:134-135, 1990 
162. Vadheim CM, Rotter JI, Maclaren NK, Riley WJ, Anderson CE: Preferential transmission of 
diabetic alleles within the HLA gene complex. N Engl J Med 315:1314-1318, 1986 
163. Pitkäniemi J, Onkamo P, Arjas E, Tuomilehto-Wolf E, Tuomilehto J: Estimation of 
transmission probabilities in families ascertained through a proband with variable age-at-onset 
disease: application to the HLA A, B and DR loci in Finnish families with type 1 diabetes. The 
DiMe Study Group. Hum Hered 50:308-317, 2000 
164. Hall JG, Solehdin F: Genomic imprinting. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi
37:401-404, 1996 
165. Guo SW, Tuomilehto J: Preferential transmission of type 1 diabetes from parents to offspring: 
fact or artifact? Genet Epidemiol 23:323-334, 2002 
166. Köbberling J, Bruggeboes B: Prevalence of diabetes among children of insulin-dependent 
diabetic mothers. Diabetologia 18:459-462, 1980 
167. Cudworth AG: Type I diabetes mellitus. Diabetologia 14:281-291, 1978 
168. Contu L, Deschamps I, Lestradet H, Hors J, Schmid M, Busson M, Benajam A, Marcelli-
Barge A, Dausset J: HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) 
families. Tissue Antigens 20:123-140, 1982 
169. Leslie RD, Delli Castelli M: Age-dependent influences on the origins of autoimmune 
diabetes: evidence and implications. Diabetes 53:3033-3040, 2004 
170. Shield JP, Wadsworth EJ, Baum JD: The genetic contribution to disease pathogenesis in 
childhood diabetes is greatest in the very young. Diabet Med 12:377-379, 1995 
171. Komulainen J, Kulmala P, Savola K, Lounamaa R, Ilonen J, Reijonen H, Knip M, Åkerblom 
HK: Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. 
Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 22:1950-1955, 1999 
172. Valdes AM, Thomson G, Erlich HA, Noble JA: Association between type 1 diabetes age of 
onset and HLA among sibling pairs. Diabetes 48:1658-1661, 1999 
86
173. Emery LM, Babu S, Bugawan TL, Norris JM, Erlich HA, Eisenbarth GS, Rewers M: 
Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk 
estimates. Pediatr Diabetes 6:136-144, 2005 
174. Hathout EH, Hartwick N, Fagoaga OR, Colacino AR, Sharkey J, Racine M, Nelsen-
Cannarella S, Mace JW: Clinical, autoimmune, and HLA characteristics of children diagnosed 
with type 1 diabetes before 5 years of age. Pediatrics 111:860-863, 2003 
175. Fava D, Gardner S, Pyke D, Leslie RD: Evidence that the age at diagnosis of IDDM is 
genetically determined. Diabetes Care 21:925-929, 1998 
176. Dahlquist GG, Mustonen LR: Clinical onset characteristics of familial versus nonfamilial 
cases in a large population-based cohort of childhood-onset diabetes patients. Diabetes Care
18:852-854, 1995 
177. American Diabetes Association: Diabetic Nephropathy. Diabetes Care 26:S94-S98, 2003 
178. Borch-Johnsen K, Kreiner S: Proteinuria: value as predictor of cardiovascular mortality in 
insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 294:1651-1654, 1987 
179. Tuomilehto J, Borch-Johnsen K, Molarius A, Forsén T, Rastenyte D, Sarti C, Reunanen A: 
Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and 
without diabetic nephropathy in Finland. Diabetologia 41:784-790, 1998 
180. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in 
type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596, 1985 
181. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in 
Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501, 1983 
182. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural 
history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985 
183. The Diabetes Control and Complications Trial Research Group (DCCT): The effect of 
intensive treatment of diabetes on the development and progression of long-term complications in 
insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993 
184. Orchard TJ, Forrest KY, Ellis D, Becker DJ: Cumulative glycemic exposure and 
microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold 
revisited. Arch Intern Med 157:1851-1856, 1997 
185. The Diabetes Control and Complications (DCCT) Research Group: Effect of intensive 
therapy on the development and progression of diabetic nephropathy in the Diabetes Control and 
Complications Trial. Kidney Int 47:1703-1720, 1995 
186. Anderson CE, Hodge SE, Rubin R, Rotter JI, Terasaki PI, Irvine WJ, Rimoin DL: A search 
for heterogeneity in insulin dependent diabetes mellitus (IDDM): HLA and autoimmune studies in 
simplex, multiplex and multigenerational families. Metabolism 32:471-477, 1983 
187. Feldt-Rasmussen B, Borch-Johnsen K, Mathiesen ER: Hypertension in diabetes as related to 
nephropathy. Early blood pressure changes. Hypertension 7:II18-20, 1985 
87
188. Parving HH, Hommel E: High blood pressure is a major factor in progression of diabetic 
nephropathy. J Diabet Complications 2:92-95, 1988 
189. Jenkins AJ, Steele JS, Janus ED, Best JD: Increased plasma apolipoprotein(a) levels in IDDM 
patients with microalbuminuria. Diabetes 40:787-790, 1991 
190. Groop PH, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen 
MR: Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes
45:974-979, 1996 
191. Fagerudd JA, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm KJ, 
Grönhagen-Riska C, Parving HH, Groop PH: Predisposition to essential hypertension and 
development of diabetic nephropathy in IDDM patients. Diabetes 47:439-444, 1998 
192. Earle K, Walker J, Hill C, Viberti G: Familial clustering of cardiovascular disease in patients 
with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677, 1992 
193. Fagerudd JA, Pettersson-Fernholm KJ, Grönhagen-Riska C, Groop PH: The impact of a 
family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic 
nephropathy in patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia 42:519-
526, 1999 
194. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, 
LaPorte RE, Drash AL: Contribution of diabetes duration before puberty to development of 
microvascular complications in IDDM subjects. Diabetes Care 12:686-693, 1989 
195. Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger 
DB: Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 
diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study 
Group. Diabetes Care 22:495-502, 1999 
196. McNally PG, Raymond NT, Swift PG, Hearnshaw JR, Burden AC: Does the prepubertal duration 
of diabetes influence the onset of microvascular complications? Diabet Med 10:906-908, 1993 
197. Donaghue KC, Fairchild JM, Craig ME, Chan AK, Hing S, Cutler LR, Howard NJ, Silink M: 
Do all prepubertal years of diabetes duration contribute equally to diabetes complications? 
Diabetes Care 26:1224-1229, 2003 
198. Donaghue KC, Fung AT, Hing S, Fairchild J, King J, Chan A, Howard NJ, Silink M: The 
effect of prepubertal diabetes duration on diabetes. Microvascular complications in early and late 
adolescence. Diabetes Care 20:77-80, 1997 
199. Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C: Incidence of end-stage 
renal disease in patients with type 1 diabetes. Jama 294:1782-1787, 2005 
200. Svensson M, Nyström L, Schon S, Dahlquist G: Age at onset of childhood-onset type 1 
diabetes and the development of end-stage renal disease: a nationwide population-based study. 
Diabetes Care 29:538-542, 2006 
201. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. 
Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989 
88
202. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the 
development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945, 1996 
203. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving 
HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992 
204. Fioretto P, Steffes MW, Barbosa J, Rich SS, Miller ME, Mauer M: Is diabetic nephropathy 
inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 48:865-869, 1999 
205. The Diabetes Control and Complications Trial Research Group (DCCT): Clustering of long-
term complications in families with diabetes in the diabetes control and complications trial. 
Diabetes 46:1829-1839, 1997 
206. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD: HbA(1c) levels are 
genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes
50:2858-2863, 2001 
207. Österholm AM, He B, Pitkäniemi J, Albinsson L, Berg T, Sarti C, Tuomilehto J, Tryggvason 
K: Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive 
linkage to a single locus on chromosome 3q. Kidney Int, 2006 
208. Dogra G, Watts GF: Genes and diabetic nephropathy: what have we learnt so far? Practical
Diabetes International: the international journal for diabetes care teams worldwide 17:84-90, 2000 
209. Andersen S, Jacobsen P, Parving HH: ACE insertion/deletion genotypes and angiotensin II 
receptor blockade in diabetic nephropathy: is there a light at the end of the tunnel? Diabetes Care
26:2962-2963, 2003 
210. Merta M, Reiterova J, Rysava R, Kmentova D, Tesar V: Genetics of diabetic nephropathy. 
Nephrol Dial Transplant 18 Suppl 5:v24-25, 2003 
211. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J: Declining incidence of 
nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18, 1994 
212. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J: Declining incidence of severe 
retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-
the Linkoping Diabetes Complications Study. Diabetologia 47:1266-1272, 2004 
213. Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH: 
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care
26:1258-1264, 2003 
214. Nishimura R, Dorman JS, Bosnyak Z, Tajima N, Becker DJ, Orchard TJ: Incidence of ESRD 
and survival after renal replacement therapy in patients with type 1 diabetes: a report from the 
Allegheny County Registry. Am J Kidney Dis 42:117-124, 2003 
215. Tryggvason G, Indridason OS, Thorsson AV, Hreidarsson AB, Palsson R: Unchanged 
incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland. Diabet Med
22:182-187, 2005 
216. Rossing P, Rossing K, Jacobsen P, Parving HH: Unchanged incidence of diabetic 
nephropathy in IDDM patients. Diabetes 44:739-743, 1995 
89
217. Tuomilehto J, Borch-Johnsen K, Molarius A, Jormanainen V, Lounamaa R, Grönhagen-Riska 
C, Reunanen A, Sarti C: The unchanging incidence of hospitalization for diabetic nephropathy in a 
population-based cohort of IDDM patients in Finland. Diabetes Care 20:1081-1086, 1997 
218. Kaprio J, Sarna S, Koskenvuo M, Rantasalo I: The Finnish Twin Registry: formation and 
compilation, questionnaire study, zygosity determination procedures, and research program. Prog
Clin Biol Res 24 Pt B:179-184, 1978 
219. Kaprio J, Koskenvuo M, Rose RJ: Population-based twin registries: illustrative applications 
in genetic epidemiology and behavioral genetics from the Finnish Twin Cohort Study. Acta Genet 
Med Gemellol (Roma) 39:427-439, 1990 
220. Diabetes Epidemiology Research International Mortality Study Group: International 
evaluation of cause-specific mortality and IDDM. Diabetes Care 14:55-60, 1991 
221. Diabetes Epidemiology Research International Mortality Study Group: Major cross-country 
differences in risk of dying for people with IDDM. Diabetes Care 14:49-54, 1991 
222. Lounamaa R: Mortality in Finnish Patients With Insulin-Dependent Diabetes Mellitus: A 
Follow-Up Study of Patients Diagnosed When Under Twenty Years of Age.  Helsinki, Finland, 
Publication of the Social Incurance Institution, 1993 
223. Tuomilehto J, Rewers M, Reunanen A, Lounamaa P, Lounamaa R, Tuomilehto-Wolf E, 
Åkerblom HK: Increasing trend in type 1 (insulin-dependent) diabetes mellitus in childhood in 
Finland. Analysis of age, calendar time and birth cohort effects during 1965 to 1984. Diabetologia
34:282-287, 1991 
224. Sarna S, Kaprio J, Sistonen P, Koskenvuo M: Diagnosis of twin zygosity by mailed 
questionnaire. Hum Hered 28:241-254, 1978 
225. Neale M: Mx: Statistical Modeling.  Richmond, 1991 
226. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC: Latent 
autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206-2212, 2005 
227. Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM: Is latent autoimmune diabetes 
in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 54 Suppl 
2:S62-67, 2005 
228. JKhoury MB, TH. Cohen BH.: Fundamentals of genetic epidemiology, 1993 
229. Hermann R, Knip M, Veijola R, Simell O, Laine AP, Åkerblom HK, Groop PH, Forsblom C, 
Pettersson-Fernholm K, Ilonen J: Temporal changes in the frequencies of HLA genotypes in 
patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia
46:420-425, 2003 
230. Kontiainen S, Scheinin T, Schlenzka A, Mäenpää J, Groop L, Koskimies S: Differences in 
HLA types in children with insulin-dependent diabetes diagnosed in 1960s, 1970s, and 1980s. 
Lancet 2:219, 1988 
231. Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, Gale EA: The rising 
incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. 
Lancet 364:1699-1700, 2004 
90
232. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group: Familial 
risk of type I diabetes in European children. Diabetologia 41:1151-1156, 1998 
233. Todd JA: From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays
21:164-174, 1999 
234. Ikäheimo I, Silvennoinen-Kassinen S, Tiilikainen A: HLA five-locus haplotypes in Finns. 
Eur J Immunogenet 23:321-328, 1996 
235. Palmer JP: Prediction, Prevention and Genetic Counseling in IDDM.  Chichester, John Wiley 
& Sons Ltd, 1996 
236. Todd JA: A protective role of the environment in the development of type 1 diabetes? Diabet 
Med 8:906-910, 1991 
237. Kolb H, Elliott RB: Increasing incidence of IDDM a consequence of improved hygiene? 
Diabetologia 37:729, 1994 
238. Viskari H, Ludvigsson J, Uibo R, Salur L, Marciulionyte D, Hermann R, Soltesz G, 
Fuchtenbusch M, Ziegler AG, Kondrashova A, Romanov A, Knip M, Hyoty H: Relationship 
between the incidence of type 1 diabetes and enterovirus infections in different European 
populations: results from the EPIVIR project. J Med Virol 72:610-617, 2004 
239. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 283:1277-
1278, 1999 
240. Field LL: Genes predisposing to IDDM in multiplex families. Genet Epidemiol 6:101-106, 1989 
241. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R: New susceptibility haplotype for 
type 1 diabetes. DIME Study Group. Lancet 2:299-302, 1989 
242. Pitkäniemi J, Onkamo P, Arjas E, Tuomilehto-Wolf E, Tuomilehto J: Estimation of 
transmission probabilities in families ascertained through a proband with variable age-at-onset 
disease: application to the HLA A, B and DR loci in Finnish families with type 1 diabetes. The 
DiMe Study Group. Hum Hered 50:308-317, 2000 
243. Martin-Villa JM, Vicario JL, Martinez-Laso J, Serrano-Rios M, Lledo G, Damiano A, 
Hawkins F, Regueiro JR, Arnaiz-Villena A: Lack of preferential transmission of diabetic HLA 
alleles by healthy parents to offspring in Spanish diabetic families. J Clin Endocrinol Metab
70:346-348, 1990 
244. Khoury MJ, Beaty TH, Liang KY: Can familial aggregation of disease be explained by 
familial aggregation of environmental risk factors? Am J Epidemiol 127:674-683, 1988 
245. Guo SW: Familial aggregation of environmental risk factors and familial aggregation of 
disease. Am J Epidemiol 151:1121-1131, 2000 
246. Nishimura R, Tajima N, Matsushima M, LaPorte RE: Puberty, IDDM, and death in Japan. 
Diabetes Epidemiology Research International Study Group. Diabetes Care 21:1674-1679, 1998 
247. Kullberg CE, Abrahamsson M, Arnqvist HJ, Finnström K, Ludvigsson J: Prevalence of 
retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes. 
Diabet Med 19:924-931, 2002 
91
248. Svensson M, Eriksson JW, Dahlquist G: Early glycemic control, age at onset, and 
development of microvascular complications in childhood-onset type 1 diabetes: a population-
based study in northern Sweden. Diabetes Care 27:955-962, 2004 
249. Hamilton J, Daneman D: Deteriorating diabetes control during adolescence: physiological or 
psychosocial? J Pediatr Endocrinol Metab 15:115-126, 2002 
250. Lane PH: Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol 283:F589-
600, 2002 
251. Kordonouri O, Danne T, Enders I, Weber B: Does the long-term clinical course of type I 
diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin 
Retinopathy Study. Eur J Pediatr 157:202-207, 1998 
252. Korth-Schutz S, Levine LS, New MI: Serum androgens in normal prepubertal and pubertal 
children and in children with precocious adrenarche. J Clin Endocrinol Metab 42:117-124, 1976 
253. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T: Analysis of 24-hour growth hormone 
profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab
78:1195-1201, 1994 
